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Abstract	  
	  
Low	  back	  pain	  (LBP)	  is	  a	  common	  chronic	  pain	  condition	  affecting	  millions	  of	  
people	  worldwide.	  Conventional	  methods	  of	  diagnosing	  LBP	  have	  provided	  limited	  
guidance;	  consequently	  most	  patients	  get	  a	  general	  diagnosis	  of	  “nonspecific”	  LBP.	  
Brain	  imaging	  has	  been	  proposed	  to	  be	  a	  method	  of	  studying	  LBP	  since	  all	  pain	  
signals	  are	  processed	  in	  the	  brain.	  Up	  till	  today,	  the	  relationship	  between	  brain	  
structure	  and	  LBP	  is	  not	  fully	  understood.	  A	  few	  studies	  have	  examined	  this	  
relationship	  but	  reported	  inconsistent	  findings.	  Additionally,	  all	  of	  those	  studies	  
examined	  the	  chronic	  LBP	  population	  and	  none	  have	  attempted	  to	  study	  
acute/subacute	  LBP	  population.	  In	  this	  study	  we	  have	  acquired	  structural	  brain	  
scans	  from	  participants	  with	  LBP	  (acute/subacute	  and	  chronic)	  and	  healthy	  
controls.	  A	  total	  of	  130	  participants	  were	  included	  in	  this	  study	  (23	  subacute	  LBP	  
participants,	  68	  chronic	  LBP	  participants,	  and	  39	  healthy	  controls).	  We	  compared	  
whole-­‐brain	  volume	  between	  each	  2	  groups	  separately	  using	  volumetric	  
measurements	  and	  using	  voxel-­‐based	  morphometry	  (VBM).	  We	  also	  examined	  
specific	  regions-­‐of-­‐interest	  (ROIs)	  of	  pain	  processing.	  Finally	  we	  conducted	  
correlation	  analyses	  between	  brain	  volumes	  and	  clinical	  outcome	  measures	  we	  
collected	  from	  the	  LBP	  participants	  in	  the	  2	  groups.	  Our	  results	  showed	  no	  
difference	  in	  whole-­‐brain	  volume	  between	  any	  of	  the	  groups	  measured	  by	  
volumetric	  measurements	  or	  VBM	  after	  correcting	  for	  multiple	  comparisons.	  We	  
noticed	  difference	  in	  2	  voxels	  (6.75	  mm3)	  in	  the	  cortical	  affective	  regions	  of	  the	  
brain	  when	  comparing	  participants	  with	  chronic	  LBP	  to	  healthy	  controls.	  Normal	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aging	  can	  lead	  to	  an	  annual	  loss	  of	  4-­‐6	  mm3	  of	  brain	  volume;	  therefore	  the	  reduction	  
we	  have	  noticed	  is	  not	  clinically	  significant.	  No	  differences	  were	  noticed	  in	  the	  other	  
ROIs.	  Finally,	  no	  correlations	  were	  noticed	  between	  any	  of	  the	  clinical	  outcome	  
measures	  and	  brain	  volumes.	  We	  calculated	  the	  effect	  size	  of	  LBP	  and	  found	  it	  to	  be	  
<0.1,	  which	  is	  considered	  a	  minimal	  effect	  size.	  Our	  conclusion	  is	  that	  LBP	  has	  
minimum	  to	  no-­‐effect	  on	  brain	  structure	  regardless	  of	  its	  duration.	  This	  information	  
is	  clinically	  important	  for	  patients,	  clinicians,	  and	  scientists	  for	  understanding	  the	  
underlying	  neurophysiological	  consequences	  of	  LBP	  and	  therapeutic	  applications.	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1.	  Low	  Back	  Pain	  Prevalence	  and	  Economic	  Impact:	  
Low	  back	  pain	  (LBP)	  is	  one	  of	  the	  most	  common	  chronic	  pain	  conditions	  
affecting	  millions	  of	  people	  worldwide	  (Hoy	  et	  al.,	  2012;	  Meucci	  et	  al.,	  2015).	  It	  is	  the	  
second	  most	  common	  reason	  for	  visiting	  a	  primary	  care	  provider	  after	  upper	  
respiratory	  tract	  infections	  (Hart	  et	  al.,	  1995;	  Andersson,	  1999).	  According	  to	  the	  
European	  Guidelines	  for	  the	  Management	  of	  Acute	  Nonspecific	  LBP	  in	  Primary	  Care,	  
it	  is	  defined	  as	  “pain	  or	  discomfort	  localized	  below	  the	  costal	  margin	  and	  above	  the	  
inferior	  gluteal	  folds,	  with	  or	  without	  leg	  pain”	  (van	  Tulder	  et	  al.,	  2006).	  Two	  
national	  surveys	  conducted	  in	  the	  Unit	  States	  revealed	  that	  about	  one	  quarter	  of	  the	  
entire	  population	  reported	  LBP	  in	  a	  period	  of	  3	  months	  (Deyo	  et	  al.,	  2006).	  Due	  to	  
its	  wide	  prevalence,	  LBP	  is	  a	  major	  economic	  burden	  on	  society.	  In	  the	  United	  
Kingdom,	  the	  annual	  estimated	  cost	  of	  LBP	  exceeded	  $19	  billion	  (Maniadakis	  and	  
Gray,	  2000).	  In	  the	  Netherlands,	  the	  direct	  annual	  cost	  of	  LBP	  exceeded	  $350	  million	  
(van	  Tulder	  et	  al.,	  1995).	  In	  Australia,	  the	  total	  annual	  cost	  of	  LBP	  exceeded	  $6	  
billion	  (Walker	  et	  al.,	  2003).	  Yet,	  the	  most	  alarming	  figure	  is	  from	  the	  most	  recently	  
published	  study	  by	  Katz	  et	  al.	  where	  they	  estimated	  the	  annual	  total	  cost	  of	  LBP	  in	  
the	  United	  States	  at	  more	  than	  $100	  billion	  (Katz,	  2006).	  
	  
2.	  Low	  Back	  Pain	  Diagnosis	  and	  Phases:	  
LBP	  can	  be	  described	  according	  to	  its	  duration	  as	  acute,	  subacute,	  or	  chronic.	  
There	  is	  no	  consistency	  in	  the	  literature	  regarding	  the	  exact	  timeline	  of	  each	  of	  these	  
phases	  (Dionne	  et	  al.,	  2008);	  however,	  most	  researchers	  would	  describe	  the	  “acute”	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phase	  as	  pain	  for	  less	  than	  3-­‐4	  weeks,	  and	  the	  “chronic”	  phase	  as	  pain	  for	  more	  than	  
3-­‐6	  months.	  There	  are	  no	  clear	  guidelines	  or	  regulations	  regarding	  the	  timeframe	  of	  
the	  subacute	  phase,	  nonetheless,	  it	  is	  the	  transitional	  phase	  between	  the	  acute	  and	  
chronic	  phases.	  Therefore	  it	  can	  be	  implied	  that	  the	  “subacute”	  phase	  of	  LBP	  is	  pain	  
between	  roughly	  4	  weeks	  and	  6	  months.	  Additionally,	  LBP	  can	  also	  be	  described	  
according	  to	  its	  cause;	  discogenic,	  arthrogenic,	  or	  myogenic.	  Yet,	  one	  of	  the	  biggest	  
distresses	  related	  to	  LBP	  is	  that	  almost	  85%	  of	  patients	  have	  no	  specific	  patho-­‐
anatomical	  diagnosis	  and	  rather	  have	  idiopathic	  or	  “nonspecific”	  LBP	  (Deyo	  and	  
Weinstein,	  2001).	  Nonspecific	  LBP	  has	  been	  defined	  as	  “tension,	  or	  soreness	  and/or	  
stiffness	  in	  the	  lower	  back	  region	  for	  which	  it	  is	  not	  possible	  to	  identify	  a	  specific	  
cause	  of	  the	  pain”	  (National	  Collaborating	  Centre	  for	  Primary,	  2009).	  This	  indicates	  
that	  patients	  visiting	  a	  physician	  will	  not	  be	  given	  a	  definitive	  diagnosis	  of	  why	  they	  
are	  having	  back	  pain.	  Instead,	  they	  merely	  get	  a	  statement	  that	  indicates	  that	  their	  
back	  pain	  has	  no	  specific	  known	  cause.	  From	  a	  healthcare	  provider’s	  perspective,	  
this	  can	  have	  drastic	  impacts	  on	  therapeutic	  practices	  due	  to	  the	  lack	  of	  a	  specific	  
diagnosis	  leading	  to	  additional	  expenses	  and	  more	  time	  spent	  trying	  to	  treat	  this	  
condition.	  From	  a	  patient’s	  perspective,	  the	  potential	  stress	  of	  not	  having	  a	  
definitive	  diagnosis	  may	  add	  to	  the	  psychosocial	  aspect	  of	  LBP,	  which	  can	  be	  a	  major	  
contributor	  to	  the	  pain	  (Ramond-­‐Roquin	  et	  al.,	  2015).	  	  
	  
Another	  major	  distress	  related	  to	  LBP	  is	  the	  fact	  that	  there	  is	  a	  big	  mismatch	  
between	  radiographic	  findings	  (spine	  MRIs)	  and	  clinical	  presentation	  or	  symptoms	  
of	  patients	  (Jensen	  et	  al.,	  1994;	  Berg	  et	  al.,	  2013).	  The	  study	  by	  Jensen	  et	  al.	  (1994)	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found	  that	  52%	  of	  asymptomatic	  individuals	  (individuals	  with	  no	  LBP)	  showed	  a	  
disc	  bulge	  on	  their	  spine	  MRI	  on	  at	  least	  one	  level,	  27%	  showed	  a	  protrusion,	  and	  
1%	  showed	  an	  extrusion.	  All	  those	  conditions	  are	  actual	  diagnoses	  of	  LBP-­‐related	  
conditions,	  yet	  none	  of	  those	  individuals	  have	  any	  pain.	  Berg	  et	  al.	  (2013)	  concluded	  
that	  findings	  from	  spine	  MRIs	  are	  not	  related	  to	  the	  intensity	  or	  degree	  of	  disability	  
caused	  by	  LBP.	  Due	  to	  all	  the	  aforementioned	  reasons,	  getting	  a	  specific	  diagnosis	  of	  
LBP	  is	  a	  very	  intricate	  job.	  
	  
Lack	  of	  a	  specific	  diagnosis	  may	  be	  one	  of	  the	  contributors	  to	  the	  progression	  
of	  acute/subacute	  LBP	  into	  recurrent	  LBP,	  and	  eventually	  into	  chronic	  LBP.	  Studies	  
show	  that	  up	  to	  75%	  of	  people	  who	  suffer	  from	  an	  acute	  attack	  of	  LBP	  can	  sustain	  
feeling	  pain	  for	  at	  least	  one	  year	  afterwards	  (Hestbaek	  et	  al.,	  2003).	  As	  a	  chronic	  
condition,	  other	  factors	  such	  as	  anxiety,	  depression,	  and	  fear	  of	  movement	  take	  
place	  simultaneously	  and	  start	  to	  play	  a	  role	  in	  pain	  processing	  (Reme	  et	  al.,	  2014).	  
The	  longer	  the	  duration	  of	  the	  condition	  is,	  the	  harder	  it	  gets	  to	  disentangle	  all	  the	  
factors	  that	  can	  lead	  to	  this	  complex	  pain	  experience,	  and	  eventually	  lead	  a	  
reduction	  in	  quality	  of	  life	  for	  those	  patients.	  Therefore,	  trying	  to	  understand	  LBP	  
starting	  from	  the	  acute	  phase,	  throughout	  the	  subacute	  phase,	  is	  very	  essential	  in	  an	  
attempt	  to	  comprehend	  its	  progression	  towards	  “chronicity”.	  	  This	  understanding	  
eventually	  might	  affect	  clinical	  practice	  in	  manners	  where	  this	  seemingly	  
unstoppable	  progression	  can	  be	  slowed	  down	  or	  even	  prevented.	  A	  number	  of	  
clinical	  outcome	  measures	  are	  used	  to	  assess	  clinical	  components	  of	  this	  condition	  
including	  pain	  intensity	  scales,	  fear	  of	  movement	  questionnaires,	  depression	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measures,	  and	  disability	  scores.	  The	  main	  clinical	  outcome	  measures	  that	  were	  used	  
in	  this	  study	  will	  be	  discussed	  in	  later	  sections	  of	  the	  introduction.	  
	  
3.	  The	  Pain	  Phenomenon:	  
In	  order	  to	  understand	  LBP,	  one	  should	  take	  a	  step	  back	  and	  try	  to	  
understand	  “pain”	  first.	  Pain	  is	  a	  very	  challenging	  phenomenon	  to	  study,	  especially	  
since	  it	  is	  a	  purely	  subjective	  sensation,	  which	  makes	  an	  objective	  understanding	  of	  
it	  complicated	  and	  problematic.	  In	  order	  to	  understand	  pain,	  one	  can	  imagine	  the	  
difference	  in	  emotions	  felt	  when	  experiencing	  a	  physically	  painful	  incident,	  and	  the	  
emotions	  felt	  when	  seeing	  a	  painful	  incident.	  This	  indicates	  that	  pain	  has	  two	  main	  
components	  to	  it;	  a	  sensory-­‐discriminative	  component	  and	  an	  affective-­‐emotional	  
component.	  The	  sensory	  component	  is	  similar	  to	  other	  feelings	  and	  senses	  we	  
experience,	  such	  as	  thirst,	  hunger,	  or	  olfaction.	  In	  other	  words,	  it	  is	  the	  perception	  of	  
a	  stimulus	  that	  is	  affecting	  a	  part	  of	  the	  human	  body	  (Craig,	  2002).	  Nociceptors	  (pain	  
receptors)	  are	  located	  in	  different	  parts	  of	  the	  body	  (cutaneous,	  visceral,	  muscular,	  
and	  in	  different	  joints)	  and	  their	  main	  function	  is	  to	  alert	  us	  about	  damaging	  -­‐	  or	  
potential	  damaging	  -­‐	  stimuli	  (Dubin	  and	  Patapoutian,	  2010).	  Just	  as	  stimulating	  the	  
olfactory	  receptors	  leads	  to	  smelling	  an	  odor,	  stimulating	  nociceptors	  (with	  high	  
levels	  of	  pressure	  or	  heat)	  can	  lead	  to	  experiencing	  physical	  pain.	  Nonetheless,	  
physical	  stimulation	  is	  not	  the	  only	  reason	  for	  experiencing	  pain.	  The	  affective	  
component	  of	  pain	  is	  another	  main	  cause	  of	  this	  experience.	  Pain	  anticipation,	  fear	  
of	  pain,	  and	  empathy	  of	  pain	  are	  all	  examples	  of	  the	  affective	  component	  of	  pain.	  In	  
this	  case,	  there	  is	  no	  role	  of	  nociceptors	  in	  experiencing	  pain,	  yet	  pain	  is	  felt	  (Auvray	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et	  al.,	  2010).	  This	  is	  mainly	  because	  pain	  has	  an	  anticipatory	  aspect	  to	  it	  (Machado	  et	  
al.,	  2014).	  The	  integration	  of	  both	  aspects,	  sensory	  and	  affective,	  leads	  to	  what	  is	  
called	  “the	  pain	  phenomenon”	  (Craig,	  2003).	  
	  
The	  two	  components	  of	  pain	  are	  processed	  in	  different	  parts/regions	  of	  the	  
brain	  (Figure	  1.1).	  According	  to	  Borsook	  et	  al.	  (2010),	  the	  main	  regions	  processing	  
the	  sensory	  aspect	  include	  the	  primary	  somatosensory	  cortex,	  thalamus,	  and	  
posterior	  insula.	  The	  affective	  pain	  processing	  regions	  include	  the	  cingulate,	  
orbitofrontal	  and	  medial	  prefrontal	  cortices,	  anterior	  insula,	  nucleus	  accumbens,	  
amygdala,	  caudate,	  thalamus,	  and	  hippocampus	  (Borsook	  et	  al.,	  2010).	  	  
	  
The	  primary	  somatosensory	  cortex	  plays	  a	  number	  of	  roles	  in	  terms	  of	  brain	  
function,	  yet	  it	  also	  plays	  a	  significant	  role	  in	  pain	  processing.	  It	  is	  one	  of	  the	  major	  
sites	  within	  the	  brain	  for	  integration	  of	  afferent	  input,	  which	  leads	  to	  sensing	  the	  
presence,	  intensity,	  and	  location	  of	  touch,	  non-­‐painful	  thermal	  stimuli,	  and	  more	  
importantly,	  pain	  (Vierck	  et	  al.,	  2013).	  
	  
The	  insula	  is	  divided	  into	  anterior	  and	  posterior	  portions.	  This	  distinction	  
has	  been	  made	  based	  on	  the	  functional	  differences	  of	  the	  portions	  of	  the	  insula.	  The	  
anterior	  insula	  is	  responsible	  for	  self-­‐awareness	  and	  feeling	  different	  emotions	  such	  
as	  happiness,	  anger,	  music	  enjoyment,	  and	  awareness	  of	  pain	  (Craig,	  2002).	  On	  the	  
other	  hand,	  the	  posterior	  insula	  is	  related	  to	  processing	  painful	  stimuli,	  mostly	  
thermal	  noxious	  stimuli	  (Brooks	  et	  al.,	  2002;	  Craig,	  2003).	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The	  cingulate	  cortex,	  and	  more	  specifically	  the	  anterior	  cingulate	  cortex,	  is	  
also	  related	  to	  pain	  processing.	  Many	  researchers	  found	  that	  the	  anterior	  cingulate	  
cortex	  is	  activated	  when	  painful	  stimuli	  were	  applied	  to	  healthy	  participants,	  which	  
indicates	  its	  role	  in	  pain	  processing	  (Craig	  et	  al.,	  1996;	  May	  et	  al.,	  1998;	  Peyron	  et	  al.,	  
2000).	  The	  orbitofrontal	  cortex	  was	  also	  found	  to	  be	  activated	  in	  different	  emotional	  
experiences,	  including	  both	  positive	  and	  negative	  emotions	  (Etkin	  et	  al.,	  2011).	  
Furthermore,	  the	  medial	  prefrontal	  cortex	  was	  found	  to	  be	  activated	  in	  painful	  
experiences	  and	  in	  feeling	  empathy	  for	  others	  experiencing	  pain	  (Lamm	  et	  al.,	  
2011).	  
	  
Not	  only	  cortical	  regions	  of	  the	  brain	  are	  involved	  in	  pain	  processing,	  but	  also	  
subcortical	  regions	  are	  involved	  as	  well.	  The	  nucleus	  accumbens	  is	  related	  to	  
multiple	  aspects	  of	  human	  behavior	  such	  as	  facilitating	  goal-­‐directed	  behaviors	  
(Goto	  and	  Grace,	  2008)	  and	  mediating	  the	  rewarding	  process	  in	  the	  brain	  (Salamone	  
et	  al.,	  2005).	  Nonetheless,	  it	  also	  plays	  a	  role	  in	  pain	  processing,	  more	  specifically	  in	  
mediating	  and	  suppressing	  pain	  (Altier	  and	  Stewart,	  1999).	  The	  amygdala	  is	  another	  
subcortical	  brain	  region	  that	  is	  associated	  with	  emotional	  processing,	  mainly	  fear	  
emotions	  (Fernando	  et	  al.,	  2013).	  Yet	  this	  is	  not	  the	  only	  function	  of	  the	  amygdala	  as	  
research	  is	  pointing	  towards	  its	  role	  as	  a	  memory	  storage	  device,	  and	  moreover	  as	  a	  
“hot	  spot”	  for	  pain	  control	  (Rouwette	  et	  al.,	  2012).	  The	  caudate	  is	  one	  of	  the	  basal	  
ganglia,	  and	  a	  recent	  literature	  review	  reported	  that	  it	  plays	  a	  role	  in	  emotional	  
processing	  but	  only	  related	  to	  sad	  emotions	  (Meerwijk	  et	  al.,	  2013).	  The	  
hippocampus	  is	  yet	  another	  brain	  region	  involved	  in	  different	  functions	  such	  as	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arousal	  and	  attention,	  memory,	  emotional	  processing	  and	  sensory-­‐motor	  
integration	  (Oddie	  and	  Bland,	  1998;	  Bird	  and	  Burgess,	  2008).	  Additionally,	  it	  is	  
found	  to	  be	  involved	  in	  processing	  pain	  signals	  (Liu	  and	  Chen,	  2009).	  Finally,	  the	  
thalamus	  is	  considered	  a	  major	  center	  that	  receives	  multiple	  projections	  from	  
different	  ascending	  pain	  pathways.	  It	  is	  not	  only	  a	  relay	  station	  for	  ascending	  
pathways,	  but	  also	  a	  major	  role	  player	  in	  processing	  pain	  signals,	  both	  sensory	  and	  
affective	  (Ab	  Aziz	  and	  Ahmad,	  2006).	  
	  
Pain	  is	  a	  very	  complex	  experience.	  It	  is	  affected	  not	  only	  by	  the	  amount	  of	  the	  
noxious	  stimulus	  but	  also	  by	  all	  the	  emotions,	  memories,	  and	  cognitive	  factors	  that	  
form	  this	  experience.	  Furthermore,	  it	  is	  not	  linearly	  related	  to	  the	  extent	  of	  
nociceptive	  input,	  especially	  in	  cases	  of	  chronic	  pain	  (Tracey	  and	  Mantyh,	  2007).	  
Studies	  examining	  different	  pain	  populations	  showed	  that	  there	  are	  structural	  brain	  
differences	  in	  populations	  with	  chronic	  pain.	  For	  instance,	  a	  number	  of	  studies	  
reported	  significantly	  lower	  cortical	  thickness	  and	  brain	  volume	  in	  participants	  with	  
fibromyalgia	  when	  compared	  to	  healthy	  controls	  (Burgmer	  et	  al.,	  2009;	  Ceko	  et	  al.,	  
2013;	  Jensen	  et	  al.,	  2013).	  In	  the	  complex	  regional	  pain	  syndrome	  population	  
studies	  have	  found	  less	  gray	  matter	  volume	  in	  different	  pain-­‐related	  regions	  such	  as	  
the	  cingulate	  and	  orbitofrontal	  frontal	  cortices	  (Geha	  et	  al.,	  2008;	  Pleger	  et	  al.,	  
2014).	  In	  general,	  such	  findings	  have	  been	  reported	  in	  almost	  all	  chronic	  pain	  
conditions	  indicating	  that	  decrease	  in	  brain	  volume	  is	  applicable	  to	  most,	  if	  not	  all,	  
pain	  conditions,	  including	  chronic	  LBP	  (Henry	  et	  al.,	  2011).	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It	  is	  very	  essential	  to	  understand	  that	  a	  painful	  experience	  can	  activate	  most,	  
and	  in	  some	  cases	  all,	  of	  the	  previously	  mentioned	  brain	  regions.	  This	  wide	  
involvement	  of	  multiple	  regions	  highlights	  the	  complexity	  of	  the	  pain	  phenomenon	  
and	  suggests	  that	  pain	  is	  not	  merely	  a	  sensory	  process	  but	  rather	  a	  complex	  
experience	  incorporating	  many	  regions	  of	  the	  brain.	  This	  is	  why	  all	  major	  regions	  
involved	  in	  pain	  processing	  were	  selected	  to	  be	  a	  part	  of	  the	  regions-­‐of-­‐interest	  
(ROI)	  analysis	  that	  was	  conducted	  in	  this	  study	  (aim	  2).	  Based	  on	  their	  function,	  
brain	  regions	  were	  assigned	  into	  a	  sensory	  mask,	  a	  cortical	  affective	  mask,	  a	  
subcortical	  affective	  mask,	  and	  a	  separate	  mask	  for	  the	  thalamus	  since	  it	  is	  involved	  
in	  both	  sensory	  and	  affective	  pain	  processing.	  Figure	  1.2	  shows	  the	  main	  masks	  that	  
we	  created	  for	  this	  study.	  
	  
4.	  Structural	  Brain	  Imaging:	  
Structural	  brain	  imaging	  is	  one	  of	  the	  major	  ways	  of	  analyzing	  the	  brain	  and	  
examining	  its	  volume.	  Volumetric	  measurements	  are	  used	  for	  calculating	  gray	  
matter	  (GM),	  white	  matter	  (WM),	  cerebro-­‐spinal	  fluid	  (CSF),	  and	  total	  intra-­‐cranial	  
volumes	  (GM+WM+CSF).	  Such	  measurements	  are	  essential	  in	  terms	  of	  explaining	  
how	  various	  brain	  matter	  volumes	  are	  different	  on	  a	  global	  level.	  However,	  
volumetric	  measurements	  do	  not	  provide	  information	  on	  the	  location	  of	  any	  
differences	  in	  brain	  volume.	  That	  is	  why	  Voxel-­‐Based	  Morphometry	  (VBM)	  has	  
become	  a	  commonly	  used	  method	  for	  examining	  brain	  volume.	  VBM	  generates	  
statistical	  probability	  brain	  maps	  of	  the	  differences	  in	  volume	  between	  groups	  of	  
subjects	  indicating	  the	  exact	  location	  of	  such	  differences	  (Ashburner	  and	  Friston,	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2000)	  (aim	  1).	  Both	  methods	  have	  been	  used	  vastly	  within	  the	  LBP	  research	  
(Apkarian	  et	  al.,	  2004;	  Schmidt-­‐Wilcke,	  2008;	  Baliki	  et	  al.,	  2011;	  Ivo	  et	  al.,	  2013;	  Ung	  
et	  al.,	  2014).	  Volumetric	  analyses,	  as	  aforementioned,	  provide	  a	  global	  view	  of	  
difference	  in	  brain	  matter	  volume	  while	  VBM	  presents	  a	  more	  focused	  and	  cluster-­‐
like	  presentation	  of	  such	  differences.	  Any	  volumetric	  differences	  occurring	  in	  the	  
brain	  that	  are	  not	  within	  a	  sufficiently	  large	  cluster	  (according	  to	  the	  cluster	  size	  
threshold	  that	  is	  set	  for	  the	  analysis)	  will	  not	  be	  identified	  by	  VBM;	  however,	  they	  
will	  be	  noticed	  in	  the	  volumetric	  analyses.	  Therefore	  a	  combination	  of	  both	  methods	  
is	  the	  most	  comprehensive	  way	  of	  examining	  brain	  volume,	  which	  is	  what	  we	  
included	  in	  this	  study.	  
	  
5.	  Low	  Back	  Pain	  and	  Brain	  Imaging:	  
With	  advantages	  within	  in	  vivo	  imaging	  techniques,	  a	  better	  understanding	  of	  
centrally	  mediated	  differences	  (within	  the	  brain)	  can	  be	  achieved.	  Brain	  imaging	  is	  
considered	  a	  safe,	  noninvasive,	  relatively	  easy	  method	  of	  examining	  the	  brain,	  its	  
volume,	  function,	  and	  neurochemistry.	  Specifically,	  magnetic	  resonance	  
spectroscopy	  (MRS),	  functional	  magnetic	  resonance	  imaging	  (fMRI),	  and	  structural	  
MRI	  studies	  have	  been	  conducted	  to	  examine	  central	  components	  of	  nociception	  
within	  LBP	  and	  other	  various	  chronic	  pain	  conditions	  (Henry,	  Chiodo	  et	  al.,	  2011).	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5.A.	  Magnetic	  Resonance	  Spectroscopy	  in	  LBP:	  
MRS	  studies	  examine	  the	  levels	  of	  different	  neurochemicals	  in	  the	  brain.	  
Studies	  found	  decreased	  levels	  of	  N-­‐acetyl	  aspartate	  (a	  neurochemical	  used	  as	  an	  
indicator	  of	  neuronal	  health)	  in	  different	  parts	  of	  the	  brain	  in	  participants	  with	  
chronic	  LBP	  (Grachev	  et	  al.,	  2000;	  Sharma	  et	  al.,	  2012).	  Others	  found	  altered	  levels	  
of	  glutamate,	  glutamine,	  myo-­‐insosytol,	  and	  choline	  in	  different	  regions	  of	  the	  brain	  
that	  are	  associated	  with	  pain	  processing	  (Gussew	  et	  al.,	  2011).	  Studies	  conducted	  in	  
our	  lab	  demonstrated	  that	  such	  neurochemical	  differences	  were	  correlated	  with	  
pain	  duration	  and	  pain	  severity	  (Sharma	  et	  al.,	  2011).	  Such	  findings	  indicate	  
abnormal	  brain	  neurochemistry	  in	  participants	  with	  chronic	  LBP.	  
	  
5.B	  Functional	  Magnetic	  Resonance	  Imaging	  in	  LBP:	  
Functional	  MRI	  studies	  examine	  the	  blood-­‐oxygen	  level-­‐dependent	  signal	  in	  
the	  brain,	  usually	  in	  response	  to	  a	  certain	  task.	  The	  assumption	  is	  that	  the	  areas	  
showing	  more	  oxygenated	  blood	  are	  the	  areas	  that	  are	  being	  activated	  in	  response	  
to	  the	  specific	  task.	  There	  have	  been	  a	  number	  of	  studies	  that	  examined	  brain	  
activation	  patterns	  in	  response	  to	  different	  tasks	  and	  stimuli	  in	  participants	  with	  
chronic	  LBP.	  Giescke	  et	  al.	  (2004)	  found	  that	  participants	  with	  chronic	  LBP	  have	  
increased	  activation	  in	  pain-­‐related	  regions	  such	  as	  primary	  and	  secondary	  
somatosensory	  cortices	  when	  compared	  to	  healthy	  controls	  (Giesecke	  et	  al.,	  2004).	  
Kobayashi	  et	  al.	  (2009)	  had	  similar	  findings	  and	  reported	  increased	  brain	  activation	  
patterns	  in	  response	  to	  mechanical	  pressure	  on	  the	  lumbar	  spine	  of	  participants	  
with	  chronic	  LBP	  in	  similar	  brain	  regions	  (Kobayashi	  et	  al.,	  2009).	  Tagliazucchi	  et	  al.	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(2010)	  examined	  resting-­‐state	  functional	  connectivity	  in	  participants	  with	  chronic	  
LBP	  and	  found	  alterations	  in	  spontaneous	  brain	  activation	  patterns	  as	  compared	  to	  
healthy	  controls	  (Tagliazucchi	  et	  al.,	  2010).	  The	  previously	  mentioned	  fMRI	  studies	  
suggest	  that	  there	  is	  potentially	  an	  altered	  state	  of	  the	  brain	  in	  participants	  with	  
chronic	  LBP	  that	  affects	  brain	  activation	  patterns.	  Some	  authors	  interpreted	  those	  
findings	  (mainly	  increased	  brain	  activation	  patterns	  in	  pain	  related	  regions)	  as	  a	  
possible	  cause	  for	  decreased	  pain	  threshold	  in	  those	  participants	  and	  increased	  pain	  
sensitivity	  (Kobayashi,	  Kurata	  et	  al.,	  2009).	  It	  is	  noteworthy	  that	  interpreting	  such	  
findings	  is	  difficult	  due	  to	  the	  complexity	  of	  the	  condition	  and	  the	  various	  study	  
designs,	  yet	  it	  may	  indicate	  an	  abnormal	  pattern	  in	  brain	  activation	  compared	  to	  
those	  without	  LBP.	  
	  
5.C.	  Structural	  Brain	  Imaging	  in	  LBP:	  
As	  previously	  described,	  structural	  MRI	  studies	  examine	  the	  structure	  and	  
volume	  of	  the	  brain,	  and	  eventually	  grant	  researchers	  a	  way	  to	  systematically	  
compare	  volumes	  between	  groups/subjects.	  There	  have	  been	  only	  seven	  studies	  in	  
this	  field	  that	  were	  conducted	  in	  the	  past	  12	  years	  (Table	  1.1).	  The	  pioneering	  work	  
of	  Apkarian	  et	  al.	  (2004)	  indicated	  a	  significant	  reduction	  of	  brain	  GM	  in	  
participants	  with	  chronic	  LBP	  as	  compared	  to	  healthy	  controls.	  Their	  findings	  
demonstrated	  a	  5-­‐11%	  reduction	  in	  neocortical	  GM	  volume,	  which	  (according	  to	  the	  
authors)	  is	  the	  equivalent	  to	  GM	  loss	  due	  to	  10-­‐20	  years	  of	  aging.	  This	  reduction	  was	  
significantly	  negatively	  correlated	  with	  the	  duration	  of	  pain	  (Apkarian,	  Sosa	  et	  al.,	  
2004).	  As	  significant	  and	  alarming	  those	  findings	  might	  be,	  the	  study	  had	  a	  number	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of	  limitations.	  The	  authors	  included	  a	  total	  of	  52	  participants	  (26	  with	  chronic	  LBP	  
and	  26	  healthy	  controls)	  aging	  from	  19-­‐70	  years	  with	  pain	  duration	  ranging	  from	  1	  
to	  28	  years.	  After	  matching	  their	  subjects	  (chronic	  LBP	  group	  to	  healthy	  controls)	  
the	  authors	  conducted	  a	  paired	  t-­‐test,	  which	  might	  not	  be	  considered	  the	  best	  
approach	  for	  different	  participants	  in	  different	  groups.	  The	  authors	  also	  did	  not	  use	  
corrections	  for	  multiple	  comparisons	  when	  they	  reported	  their	  results,	  when	  
instead	  they	  did	  1000	  permutations	  for	  their	  analysis.	  
	  
In	  an	  attempt	  to	  overcome	  some	  of	  these	  limitations	  a	  number	  of	  papers	  
were	  published	  subsequently	  within	  this	  arena,	  but	  not	  without	  some	  
inconsistencies.	  Baliki	  et	  al.	  (2011)	  and	  Ivo	  et	  al.	  (2013)	  had	  similar	  findings	  
regarding	  decreased	  whole-­‐brain	  GM	  volume	  in	  participants	  with	  chronic	  LBP	  
compared	  to	  healthy	  controls.	  Baliki	  et	  al.	  (2011)	  had	  4	  groups	  in	  their	  study;	  
chronic	  LBP	  (36	  participants),	  knee	  osteoarthritis	  (20	  participants),	  complex	  
regional	  pain	  syndrome	  (28	  participants),	  and	  healthy	  controls	  (46	  participants).	  
They	  detected	  GM	  volume	  differences	  only	  in	  the	  chronic	  LBP	  when	  compared	  to	  
healthy	  controls;	  the	  other	  groups	  did	  not	  show	  volumetric	  differences.	  For	  their	  
voxel-­‐based	  analysis	  they	  split	  the	  brain	  into	  82	  ROIs	  and	  examined	  the	  correlation	  
of	  brain	  volumes	  extracted	  from	  each	  of	  those	  regions	  with	  clinical	  outcome	  
measures	  such	  as	  depression	  symptoms,	  anxiety,	  and	  medications.	  No	  correlations	  
were	  noticed	  between	  those	  outcome	  measures	  and	  the	  brain	  volumes.	  This	  places	  a	  
question	  mark	  on	  the	  validity	  of	  the	  differences	  they	  noticed	  before.	  If	  those	  
volumetric	  differences	  were	  not	  correlated	  with	  the	  clinical	  symptoms	  of	  LBP	  then	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they	  might	  not	  be	  related	  to	  LBP	  to	  start	  with.	  Another	  limitation	  of	  this	  study	  is	  that	  
the	  authors	  mention	  using	  Bonferroni-­‐Holm	  correction	  for	  multiple	  comparisons;	  
however,	  throughout	  the	  article	  the	  p-­‐value	  at	  which	  such	  corrections	  took	  place	  is	  
not	  mentioned.	  Ivo	  et	  al.	  (2013)	  compared	  2	  groups	  of	  14	  participants	  in	  each;	  one	  
with	  chronic	  LBP	  participants	  and	  the	  other	  with	  healthy	  controls.	  Their	  results	  
show	  decreased	  GM	  volume	  in	  the	  middle	  cingulate,	  thalamus,	  and	  dorsolateral	  
prefrontal	  cortex.	  They	  also	  detected	  a	  negative	  correlation	  between	  anxiety	  scores	  
and	  GM	  volume	  in	  the	  anterior	  cingulate.	  Yet,	  their	  volumetric	  results	  were	  based	  on	  
analyses	  conducted	  without	  correcting	  for	  multiple	  comparisons.	  Instead	  they	  used	  
puncorrected	  <	  0.001	  and	  a	  threshold	  of	  100	  voxels.	  Many	  brain	  imaging	  studies	  have	  
used	  this	  approach;	  however,	  it	  is	  not	  the	  recommended	  method	  to	  use	  with	  VBM,	  
according	  to	  its	  creators	  (Ashburner	  and	  Friston,	  2000).	  Other	  researchers	  found	  
different	  results	  when	  conducting	  similar	  studies.	  
	  
Schmidte-­‐Wilcke	  et	  al.	  (2006),	  Buckalew	  et	  al.	  (2008),	  Ung	  et	  al.	  (2012),	  and	  
Dolman	  et	  al.	  (2014)	  did	  not	  find	  differences	  in	  whole-­‐brain	  GM	  volume	  when	  
comparing	  participants	  with	  chronic	  LBP	  to	  healthy	  controls.	  Schmidte-­‐Wilcke	  et	  al.	  
(2006)	  had	  a	  total	  of	  36	  participants	  who	  were	  split	  into	  2	  groups,	  18	  with	  chronic	  
LBP	  and	  18	  healthy	  controls.	  Their	  results	  showed	  no	  differences	  in	  overall	  GM	  
volume.	  However,	  they	  did	  notice	  some	  differences	  when	  using	  VBM	  in	  the	  
somatosensory	  cortex	  and	  brainstem.	  Yet	  those	  findings	  were	  also	  without	  using	  
corrections	  for	  multiple	  comparisons.	  Moreover,	  they	  conducted	  correlation	  
analyses	  between	  pain	  duration	  and	  intensity	  and	  brain	  volumes.	  No	  correlation	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was	  noticed	  between	  pain	  duration	  and	  brain	  volume,	  but	  they	  noticed	  a	  negative	  
correlation	  between	  pain	  intensity	  and	  brain	  volume.	  Nonetheless,	  they	  also	  noticed	  
some	  increase	  in	  GM	  volume	  in	  the	  basal	  ganglia	  and	  the	  thalamus,	  which	  is	  the	  
opposite	  of	  what	  has	  been	  reported	  about	  the	  thalamus	  in	  other	  studies	  (Apkarian,	  
Sosa	  et	  al.,	  2004;	  Gustin	  et	  al.,	  2011).	  Buckalew	  et	  al.	  (2008)	  studied	  a	  total	  of	  16	  
participants,	  8	  with	  chronic	  LBP	  and	  8	  healthy	  controls.	  They	  reported	  some	  trends	  
of	  decreased	  GM	  volume;	  however,	  they	  also	  reported	  that	  none	  of	  those	  results	  
survived	  corrections	  for	  multiple	  comparisons.	  Additionally,	  none	  of	  the	  
correlations	  they	  conducted	  between	  clinical	  outcome	  measures	  and	  brain	  volumes	  
were	  significant.	  Ung	  et	  al.	  (2012)	  examined	  94	  participants,	  47	  with	  chronic	  LBP	  
and	  47	  healthy	  controls.	  The	  overall	  VBM	  analysis	  did	  not	  reveal	  any	  between-­‐group	  
differences.	  However,	  they	  also	  mentioned	  some	  trends	  showing	  differences	  in	  
brain	  volume	  (exhibiting	  both	  increase	  and	  decrease	  in	  GM	  volume)	  in	  regions	  such	  
as	  primary	  somatosensory	  and	  motor	  cortices	  and	  middle	  occipital	  lobe	  when	  
corrections	  for	  multiple	  comparisons	  were	  not	  used.	  Finally,	  Dolman	  et	  al.	  (2014)	  in	  
the	  most	  recently	  published	  study	  examined	  28	  participants,	  14	  with	  chronic	  LBP	  
and	  14	  healthy	  controls.	  They	  found	  some	  volumetric	  differences	  between	  groups;	  
however,	  none	  of	  those	  trends	  survived	  the	  corrections	  for	  multiple	  comparisons	  
and	  controlling	  for	  other	  covariates.	  Their	  conclusion	  was	  that	  any	  volumetric	  
differences	  that	  were	  noticed	  in	  the	  brain	  when	  comparing	  participants	  with	  LBP	  
and	  healthy	  controls	  were	  reduced	  -­‐	  or	  even	  eliminated	  -­‐	  when	  controlling	  for	  other	  
major	  contributing	  factors	  (such	  as	  age	  and	  sex),	  and	  after	  correcting	  for	  multiple	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comparisons.	  As	  noticed,	  there	  is	  a	  lot	  of	  inconsistency	  in	  the	  literature	  regarding	  
the	  effect	  of	  LBP	  on	  brain	  volume.	  	  
	  
There	  is	  a	  number	  of	  reasons	  for	  such	  variations	  in	  results	  such	  as	  using	  1)	  
different	  magnitude	  of	  scanners	  (1.5	  vs.	  3	  Tesla	  scanners),	  2)	  different	  age	  ranges,	  
3)	  different	  inclusion/exclusion	  criteria	  of	  participants,	  4)	  relatively	  small	  sample	  
size	  (in	  most	  papers),	  and	  5)	  various	  different	  data	  processing	  parameters.	  Thus,	  
such	  inconsistent	  findings	  do	  not	  provide	  a	  clear	  understanding	  of	  possible	  
structural	  brain	  differences	  associated	  with	  chronic	  LBP.	  Therefore,	  the	  main	  goal	  
of	  this	  study	  was	  to	  determine	  whether	  there	  are	  any	  structural	  whole-­‐brain	  
differences	  in	  participants	  with	  subacute	  and	  chronic	  LBP	  compared	  to	  healthy	  
controls.	  Furthermore,	  we	  aimed	  to	  examine	  ROIs	  that	  are	  related	  to	  pain	  
processing	  which	  can	  provide	  a	  more	  focused	  view	  on	  those	  regions.	  Additionally,	  
we	  wanted	  to	  determine	  whether	  there	  are	  any	  correlations	  between	  clinical	  
outcome	  measures	  related	  to	  LBP	  and	  the	  normalized	  whole-­‐brain	  volumes.	  In	  
order	  to	  achieve	  those	  aims	  we	  utilized	  a	  larger	  sample	  size,	  used	  clearly	  defined	  
inclusion/exclusion	  criteria,	  and	  used	  the	  strictest	  methods	  of	  data	  analyses	  and	  
corrections	  for	  multiple	  comparisons.	  	  
	  
6.	  Significance:	  
Up	  to	  85%	  of	  LBP	  cases	  do	  not	  have	  a	  specific	  diagnosis,	  which	  ends	  up	  being	  
diagnosed	  as	  “nonspecific”	  and	  eventually	  also	  treated	  “nonspecifically”.	  Moreover,	  
chronic	  pain	  conditions	  can	  be	  present	  due	  to	  structural	  brain	  differences	  without	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the	  presence	  of	  peripheral	  causes	  (Gustin,	  Peck	  et	  al.,	  2011).	  This	  indicates	  that	  as	  
pain	  advances	  into	  a	  chronic	  case	  (like	  in	  chronic	  LBP)	  central	  differences	  in	  the	  
brain	  can	  be	  related	  to	  experiencing	  pain.	  Therefore,	  in	  our	  study	  we	  aimed	  to	  
determine	  the	  structural	  brain	  differences	  that	  may	  accompany	  LBP	  (in	  both	  
subacute	  and	  chronic	  phases).	  Understanding	  such	  potential	  differences	  can	  have	  
significant	  impacts	  on	  clinical	  practice.	  Findings	  from	  this	  study	  can	  be	  directed	  
towards	  healthcare	  professionals	  in	  assisting	  patients	  suffering	  from	  LBP.	  If	  we	  
were	  able	  to	  reject	  the	  null	  hypotheses	  (and	  detect	  volumetric	  differences	  in	  the	  
brain)	  then	  that	  would	  indicate	  a	  major	  central	  role	  of	  brain	  structure	  in	  relation	  to	  
LBP.	  At	  the	  moment,	  sensory	  pain	  modulation	  and	  approaches	  targeted	  to	  treat	  the	  
lower	  back	  are	  mostly	  focused	  on	  the	  spine.	  Nonetheless,	  clinicians	  are	  starting	  to	  
recognize	  the	  affective	  aspect	  of	  chronic	  pain	  and	  how	  important	  it	  is	  to	  address	  this	  
component	  when	  it	  comes	  to	  treating	  patients.	  If	  our	  findings	  suggest	  central	  
structural	  differences	  in	  the	  brain,	  whether	  in	  the	  chronic	  or	  the	  subacute	  phases,	  
then	  clinicians	  could	  benefit	  from	  that	  information	  by	  modifying	  their	  treatment	  
methods.	  This	  can	  lead	  to	  a	  new	  era	  of	  dealing	  with	  LBP	  from	  a	  perspective	  that	  is	  
more	  inclined	  towards	  affective	  and	  emotional	  interventions.	  Two	  previous	  studies	  
showed	  that	  with	  the	  appropriate	  intervention,	  differences	  in	  brain	  structure	  and	  
function	  could	  be	  reversed	  (Baliki	  et	  al.,	  2008;	  Seminowicz	  et	  al.,	  2011).	  Given	  that	  
such	  brain	  differences	  may	  be	  reversible,	  we	  might	  be	  able	  to	  provide	  people	  with	  
chronic	  LBP	  with	  better	  treatment	  approaches.	  Moreover,	  clinicians	  can	  potentially	  
intervene	  with	  aggressive	  treatment	  methods	  to	  control	  LBP	  during	  the	  subacute	  
phase	  and	  possibly	  slow	  down	  its	  progression,	  or	  even	  prevent	  it	  from	  taking	  place.	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On	  the	  other	  hand,	  if	  we	  fail	  to	  reject	  the	  null	  hypotheses	  (do	  not	  detect	  
volumetric	  differences)	  such	  results	  can	  still	  add	  a	  lot	  to	  the	  body	  of	  knowledge	  
related	  to	  this	  field.	  Not	  being	  able	  to	  detect	  any	  structural	  brain	  differences	  in	  
participants	  with	  subacute	  or	  chronic	  LBP	  can	  be	  a	  very	  calming	  piece	  of	  
information	  for	  the	  millions	  of	  people	  around	  the	  world	  suffering	  from	  LBP.	  This	  
would	  indicate	  that	  maybe	  there	  are	  functional	  and	  neurochemical	  differences	  
taking	  place	  in	  the	  brain,	  however	  not	  structural	  differences.	  This	  would	  give	  hope	  
for	  patients	  with	  LBP	  that	  their	  condition	  might	  still	  be	  manageable	  and	  that	  there	  is	  
hope	  for	  them	  to	  get	  rid	  of	  their	  chronic	  pain.	  Of	  course,	  this	  is	  only	  way	  down	  this	  
path	  of	  research,	  a	  lot	  of	  further	  research	  will	  be	  required	  to	  get	  to	  the	  point	  where	  
findings	  can	  have	  significant	  impacts	  on	  clinical	  practice.	  
	  
7.	  Innovation:	  
This	  study	  was	  the	  first	  to	  examine	  LBP	  within	  the	  two	  main	  components	  of	  
pain;	  the	  sensory	  and	  affective	  components.	  It	  is	  of	  paramount	  importance	  to	  
understand	  that	  pain	  is	  a	  very	  complex	  phenomenon	  that	  is	  not	  only	  related	  to	  
sensory	  input,	  but	  also	  to	  affective	  components.	  Memory	  and	  emotion	  play	  a	  crucial	  
role	  in	  pain	  processing	  as	  well	  (Ploghaus	  et	  al.,	  1999).	  Therefore	  understanding	  the	  
complexity	  of	  this	  composite	  phenomenon	  can	  have	  significant	  impacts	  on	  
rehabilitation	  in	  general,	  and	  physical	  therapy	  practice	  more	  specifically.	  Moreover,	  
in	  this	  study	  we	  used	  strict	  inclusion/exclusion	  criteria	  for	  our	  participant	  
recruitment	  (which	  was	  a	  limitation	  of	  the	  previous	  studies	  in	  this	  field).	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Additionally,	  we	  examined	  the	  correlation	  of	  the	  Fear	  Avoidance	  Belief	  
Questionnaire,	  which	  is	  an	  instrument	  developed	  for	  the	  assessment	  of	  patients’	  
beliefs	  on	  how	  physical	  activity	  and	  work	  affect	  their	  LBP	  (Waddell	  et	  al.,	  1993),	  
with	  the	  normalized	  whole-­‐brain	  volumes,	  which	  has	  not	  been	  done	  previously.	  
	  
In	  terms	  of	  data	  analysis	  we	  created	  sensory	  and	  affective	  brain	  masks	  for	  
the	  pain	  processing	  regions.	  This	  method	  of	  analysis	  has	  not	  been	  applied	  in	  any	  of	  
the	  previous	  studies,	  which	  may	  present	  valuable	  insights	  into	  those	  pain	  regions.	  
Finally,	  there	  have	  been	  no	  previous	  studies	  that	  examined	  the	  subacute	  LBP	  
population.	  This	  was	  the	  first	  study	  to	  address	  this	  population	  and	  include	  it	  in	  a	  
brain	  imaging	  study	  to	  examine	  the	  potential	  brain	  differences	  in	  this	  group	  of	  
patients.	  Findings	  related	  to	  the	  subacute	  population	  will	  be	  very	  essential	  in	  terms	  
of	  their	  effects	  on	  clinical	  practice	  (more	  details	  on	  this	  are	  presented	  in	  Chapter	  II).	  
	  
8.	  Clinical	  Outcome	  Measures:	  
In	  this	  study	  we	  examined	  the	  clinical	  presentation	  of	  our	  participants.	  We	  
were	  interested	  in	  5	  main	  measures:	  pain	  duration,	  pain	  intensity,	  fear	  of	  
movement,	  depression,	  and	  disability.	  Those	  measures,	  since	  they	  are	  related	  to	  
LBP,	  were	  only	  collected	  from	  participants	  with	  LBP	  and	  not	  from	  the	  healthy	  
controls.	  The	  following	  section	  is	  a	  brief	  description	  of	  each	  one	  of	  the	  outcome	  
measures.	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8.A.	  Pain	  Duration:	  
Pain	  duration	  is	  the	  subjective	  duration	  of	  which	  participants	  have	  been	  
complaining	  of	  LBP	  for.	  Unfortunately	  there	  is	  no	  objective	  method	  of	  measuring	  the	  
duration	  of	  pain	  other	  than	  personal	  report	  from	  each	  participant,	  and	  this	  was	  how	  
we	  collected	  this	  data.	  For	  the	  chronic	  LBP	  participants	  they	  were	  asked	  about	  the	  
duration	  of	  their	  pain	  in	  years,	  for	  the	  subacute	  LBP	  participants	  they	  were	  asked	  
about	  it	  in	  months.	  For	  data	  analyses	  purposes,	  all	  pain	  durations	  were	  converted	  
into	  months	  for	  all	  participants.	  	  
	  
8.B.	  Pain	  Intensity:	  
Pain	  intensity	  is	  the	  subjective	  rating	  of	  severity	  of	  pain	  measured	  by	  the	  
Numeric	  Rating	  Scale	  (NRS).	  The	  NRS	  is	  a	  0-­‐10	  scale	  that	  expresses	  the	  level	  of	  pain	  
experienced	  by	  the	  participant,	  with	  0	  indicating	  no	  pain	  and	  10	  indicating	  the	  
worst	  pain	  imaginable.	  The	  NRS	  is	  a	  widely	  used	  measure	  that	  has	  been	  utilized	  in	  
many	  studies	  examining	  pain	  levels	  (Chapman	  et	  al.,	  2011).	  
	  	  
8.C.	  Fear	  Avoidance	  Belief	  Questionnaire:	  
Fear	  Avoidance	  Belief	  Questionnaire	  (FABQ)	  is	  an	  instrument	  used	  to	  
measure	  the	  impact	  of	  LBP	  on	  work	  and	  physical	  activity	  (Waddell,	  Newton	  et	  al.,	  
1993).	  This	  instrument	  is	  a	  16-­‐item	  questionnaire	  with	  each	  item	  being	  scored	  from	  
0-­‐6.	  Higher	  scores	  indicate	  higher	  levels	  of	  fear	  avoidance	  beliefs	  (Appendix	  1).	  The	  
questionnaire	  is	  made	  of	  2	  sub-­‐scales:	  work	  subscale	  (7	  items),	  and	  a	  physical	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activity	  sub-­‐scale	  (4	  items).	  This	  instrument	  has	  been	  validated	  in	  different	  studies	  
and	  found	  to	  be	  a	  valid	  and	  reliable	  instrument	  (Swinkels-­‐Meewisse	  et	  al.,	  2003).	  
	  
8.D.	  Beck	  Depression	  Inventory-­‐II:	  
Beck	  Depression	  Inventory-­‐II	  (BDI-­‐II)	  is	  an	  instrument	  used	  to	  measure	  the	  
level	  of	  depressive	  symptoms.	  It	  is	  made	  of	  21	  questions	  with	  each	  being	  scored	  
from	  0-­‐3.	  Higher	  scores	  indicate	  more	  depressive	  symptoms	  (Appendix	  2).	  The	  BDI-­‐
II	  has	  been	  validated	  in	  many	  studies	  including	  studies	  examining	  LBP	  participants	  
(Wang	  and	  Gorenstein,	  2013).	  
	  
8.E.	  Oswestry	  Disability	  Index:	  
The	  Oswestry	  Disability	  Index	  (ODI)	  is	  a	  tool	  that	  is	  used	  to	  quantify	  
individual	  disability	  as	  a	  result	  of	  LBP	  (Fairbank	  et	  al.,	  1980).	  The	  ODI	  is	  made	  of	  10	  
questions	  with	  each	  being	  scored	  from	  0-­‐5.	  Higher	  scores	  indicate	  higher	  levels	  of	  
disability	  (Fairbank	  and	  Pynsent,	  2000;	  Joshi	  et	  al.,	  2013).	  Each	  one	  of	  those	  
questions	  addresses	  a	  different	  aspect	  of	  daily	  living	  such	  as	  personal	  care,	  lifting,	  
walking,	  sitting,	  and	  social	  life	  (Appendix	  3).	  	  
	  
9.	  Aims	  and	  Hypotheses:	  
In	  conclusion,	  the	  main	  aims	  and	  hypotheses	  of	  this	  study	  were:	  
Aim	  1:	  To	  determine	  whether	  participants	  with	  subacute	  and	  chronic	  LBP	  have	  
altered	  whole-­‐brain	  volume	  compared	  to	  healthy	  controls.	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Hypothesis	  1a:	  Volumetric	  measurements	  of	  normalized	  whole-­‐brain	  volume	  will	  show	  
less	  volume	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  as	  compared	  to	  healthy	  controls,	  
and	  less	  volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypothesis	  1b:Voxel-­‐wise	  whole-­‐brain	  volume	  determined	  by	  VBM	  will	  show	  less	  GM	  
volume	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  as	  compared	  to	  healthy	  controls,	  and	  
less	  volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Aim	  2:	  To	  determine	  whether	  participants	  with	  subacute	  and	  chronic	  LBP	  have	  
altered	  regional	  brain	  volume	  compared	  to	  healthy	  controls.	  
	  
Hypothesis	  2a:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  sensory	  
regions	  (primary	  somatosensory	  cortex	  and	  posterior	  insula)	  in	  the	  subacute	  and	  
chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  the	  chronic	  
group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypothesis	  2b:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  cortical	  
affective	  regions	  (cingulate,	  orbitofrontal,	  and	  medial	  prefrontal	  cortices,	  and	  anterior	  
insula)	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  
volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypothesis	  2c:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  subcortical	  
affective	  regions	  (nucleus	  accumbens,	  amygdala,	  caudate,	  and	  hippocampus)	  in	  the	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subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  the	  
chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypothesis	  2d:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  thalamus	  in	  
the	  subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  
the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Aim	  3:	  To	  determine	  the	  relationship	  between	  clinical	  outcome	  measures	  and	  
normalized	  whole-­‐brain	  volume	  within	  both	  subacute	  and	  chronic	  LBP	  
groups.	  
	  
In	  both	  the	  subacute	  and	  chronic	  LBP	  groups	  
Hypothesis	  3a:	  Pain	  duration	  will	  be	  negatively	  correlated	  with	  normalized	  whole-­‐
brain	  volume.	  
	  
Hypothesis	  3b:	  Pain	  intensity	  will	  be	  negatively	  correlated	  with	  normalized	  whole-­‐
brain	  volume.	  
	  
Hypothesis	  3c:	  Fear	  avoidance	  (measured	  by	  the	  Fear	  Avoidance	  Belief	  Questionnaire)	  
will	  be	  negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	  	  
	  
Hypothesis	  3d:	  Disability	  scores	  (measured	  by	  the	  Oswestery	  Disability	  Index)	  will	  be	  
negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	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Hypothesis	  3e:	  Depressive	  symptoms	  (measured	  by	  Beck’s	  Depression	  Inventory-­‐II)	  will	  
be	  negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	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10.	  Figures:	  
Figure	  1.1:	  Brain	  regions	  involved	  in	  pain	  processing.	  
	  
Borsook	  et	  al.	  2010	  
	  
A:	  Amygdala,	  ACC:	  Anterior	  cingulate	  cortex,	  Cer:	  cerebellum,	  H:	  Hypothalamus,	  Ins:	  
Insula,	  l,	  m:	  lateral	  and	  medial	  thalamus,	  M1:	  Primary	  motor	  cortex,	  NA:	  Nucleus	  
accumbens,	  PAG:	  Periaqueductal	  gray,	  PFC:	  prefrontal	  cortex,	  PPC:	  Posterior	  
parietal	  cortex,	  S1	  &	  S2:	  Primary	  &	  secondary	  somatosensory	  cortex,	  SMA:	  
Supplementary	  motor	  area.	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Figure	  1.2:	  Brain	  masks	  created	  for	  specific	  ROIs.	  
	  
	  1.2	  a	   	  	  	  	  	  	  	  	  	   	  1.2	  b	  
	  
	  




1.2	  a:	  Sensory	  mask	  (somatosensory	  cortex	  and	  posterior	  Insula).	  1.2	  b:	  Cortical	  
affective	  mask	  (Cingulate,	  Orbitofrontal,	  and	  Medial	  Prefrontal	  cortices,	  and	  anterior	  
Insula).	  1.3	  c:	  Sub-­‐cortical	  affective	  mask	  (Nucleus	  Accumbens,	  Amygdala,	  Caudate	  
nucleus,	  and	  Hippocampus).	  1.4	  d:	  Thalamus	  mask.	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11.	  Tables:	  
Table	  1.1:	  Summary	  of	  previous	  structural	  brain	  imaging	  studies.	  
	  

















Yes	   Yes	  
(DLPFC	  and	  
Th)	  







No	   Yes	  
(S1	  and	  
DLPFC)	  
No	   Yes	  
Buckalew	  
et	  al.,	  2006	  
16	  
(8	  cLBP,	  8	  
HC)	  
No	   Yes	  
(parietal	  
cortex)	  
No	   No	  





Yes	   Yes	  
(insula)	  
No	   No	  





No	   No	   No	   No	  





Yes	   Yes	  
(DLPFC,	  CC,	  
Th)	  






No	   No	   No	   No	  
	  
NGM:	  Normalized	  gray	  matter,	  VBM:	  Voxel-­‐based	  morphometry,	  cLBP:	  Chronic	  low	  
back	  pain,	  HC:	  Healthy	  controls,	  DLPFC:	  Dorsolateral	  Prefrontal	  cortex,	  Th:	  
Thalamus,	  S1:	  Primary	  Somatosensory	  cortex,	  CC:	  Cingulate	  cortex.	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1.	  Overview:	  
Low	  back	  pain	  (LBP)	  is	  one	  of	  the	  most	  common	  conditions	  worldwide	  (Hoy,	  
Bain	  et	  al.,	  2012;	  Meucci,	  Fassa	  et	  al.,	  2015).	  Recent,	  brain	  imaging	  studies	  have	  
found	  potential	  differences	  in	  brain	  function	  and	  neurochemistry	  in	  people	  with	  
chronic	  LBP	  when	  compared	  to	  healthy	  controls.	  Although,	  findings	  related	  to	  
structural	  brain	  differences	  are	  inconsistent	  in	  the	  literature,	  it	  is	  important	  to	  
investigate	  if	  structure	  differences	  occur	  in	  LBP,	  and	  if	  so	  how	  soon	  following	  the	  
initial	  episode	  of	  LBP.	  No	  previous	  brain	  imaging	  research	  has	  been	  conducted	  on	  
LBP	  in	  acute	  and	  subacute	  phase	  (pain	  <	  6	  months).	  The	  subacute	  phase	  of	  LBP	  is	  
essential	  to	  study	  since	  it	  is	  the	  transitional	  phase	  into	  chronic	  LBP.	  The	  lack	  of	  
studies	  in	  this	  phase	  has	  been	  hindering	  physicians	  and	  clinicians’	  ability	  to	  
implement	  effective	  treatments	  to	  patients.	  We	  do	  not	  know	  if	  any	  brain	  differences	  
(structural,	  functional,	  or	  neurochemical)	  take	  place	  in	  acute/subacute	  phases	  of	  
LBP.	  Therefore,	  we	  aimed	  to	  investigate	  this	  population	  and	  examine	  brain	  volumes	  
in	  people	  with	  subacute	  LBP,	  and	  examine	  whether	  the	  clinical	  presentation	  of	  those	  
participants	  correlate	  with	  their	  brain	  volume.	  
	  
Not	  only	  brain	  imaging	  studies	  are	  lacking	  regarding	  the	  subacute	  
population,	  even	  clinical	  studies	  are	  also	  very	  limited	  and	  scarce.	  There	  are	  a	  
number	  of	  possible	  reasons	  for	  why	  such	  research	  is	  limited.	  First,	  there	  is	  still	  no	  
clear	  definition	  of	  a	  timeline	  for	  subacute	  LBP.	  Researchers	  have	  defined	  it	  ranging	  
from	  3	  weeks	  up	  to	  one	  year	  in	  some	  cases	  (Chanda	  et	  al.,	  2011),	  which	  is	  a	  huge	  
timeframe	  that	  adds	  a	  lot	  of	  heterogeneity	  to	  this	  population	  making	  it	  much	  more	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harder	  to	  study.	  Second,	  as	  from	  our	  experience,	  subject	  recruitment	  can	  be	  very	  
challenging	  and	  difficult.	  Given	  that	  subacute	  LBP	  has	  a	  relatively	  narrow	  window	  –	  
an	  average	  of	  less	  than	  6	  months	  -­‐	  recruiting	  participants	  can	  be	  a	  major	  challenge.	  
Therefore,	  only	  1	  paper	  has	  discussed	  the	  clinical	  presentation	  of	  this	  population.	  In	  
this	  paper	  by	  Chanda	  et	  al.	  (2011)	  explained	  the	  clinical	  characteristics	  of	  
participants	  with	  subacute	  LBP	  as	  compared	  to	  participants	  with	  chronic	  LBP.	  Their	  
conclusions	  were	  that	  participants	  with	  subacute	  LBP	  have	  less	  pain	  intensity	  on	  a	  
visual	  analogue	  scale	  and	  less	  referral	  pain	  pattern	  (unilateral	  compared	  to	  bilateral	  
leg	  pain)	  compared	  to	  participants	  with	  chronic	  LBP.	  All	  other	  outcome	  measures	  
they	  examined	  (like	  depression	  and	  sensory	  and	  affective	  components	  of	  pain)	  were	  
not	  significantly	  different	  between	  groups	  after	  correcting	  for	  pain	  intensity.	  With	  a	  
total	  of	  77	  participants	  in	  this	  single	  study,	  more	  research	  is	  needed	  to	  have	  a	  better	  
understanding	  of	  this	  population.	  
	  	  
Subacute	  LBP	  is	  defined	  as	  pain	  lasting	  for	  6	  months	  or	  less	  following	  the	  
initial	  episode	  of	  back	  pain.	  Understanding	  central	  mechanisms	  of	  pain	  during	  the	  
subacute	  phase	  is	  important	  for	  the	  development	  of	  effective	  and	  individualized	  
rehabilitation	  approaches	  that	  are	  currently	  lacking.	  A	  good	  understanding	  of	  such	  
mechanisms	  might	  aid	  researchers	  in	  dissecting	  this	  progression	  and	  may	  help	  to	  
slow	  down	  or	  prevent	  development	  of	  chronicity	  of	  LBP.	  To	  date	  most	  studies	  have	  
explored	  pain-­‐related	  neural	  differences	  in	  the	  chronic	  phase	  of	  LBP.	  Therefore,	  we	  
intended	  to	  examine	  this	  population	  from	  a	  brain	  imaging	  perspective.	  The	  long-­‐
term	  goal	  of	  this	  project	  was	  to	  understand	  the	  neurophysiological	  factors	  within	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the	  subacute	  phase	  that	  may	  lead	  to	  chronicity	  of	  LBP.	  The	  main	  objective	  was	  to	  
determine	  whether	  there	  are	  any	  brain	  volumetric	  differences	  in	  participants	  with	  
subacute	  LBP	  on	  the	  whole-­‐brain	  level	  and	  within	  pain	  processing	  regions.	  
	  
While	  clinical	  questionnaires	  and	  laboratory-­‐based	  methods	  of	  testing	  pain	  
provide	  patient	  perspective	  and	  self-­‐reported	  pain	  threshold,	  these	  methods	  do	  not	  
define	  the	  specific	  neurophysiology	  consequences	  of	  pain,	  more	  specifically	  within	  
the	  brain.	  Non-­‐invasive	  brain	  imaging	  methods	  can	  be	  used	  as	  a	  tool	  to	  examine	  
such	  effects.	  Examining	  the	  relationship	  between	  patient-­‐reported	  pain	  and	  
functional	  outcomes	  and	  structural	  differences	  within	  the	  brain	  allows	  us	  to	  gain	  
insights	  into	  the	  neurophysiological	  mechanisms	  of	  pain	  processing.	  Investigating	  
pain-­‐processing	  regions	  in	  an	  early	  timeframe	  of	  pathology	  may	  improve	  our	  
understanding	  of	  how	  and	  why	  certain	  patients	  develop	  chronic	  pain.	  This	  
information	  can	  be	  used	  in	  future	  studies	  to	  identify	  which	  individuals	  may	  respond	  
to	  specific	  therapies,	  either	  rehabilitation-­‐based	  or	  pharmacological,	  such	  that	  
personalized	  treatments	  can	  be	  employed.	  
	  
2.	  Background:	  
2.A.	  Low	  Back	  Pain:	  
LBP	  is	  a	  medical	  condition	  that	  affects	  almost	  85%	  of	  the	  adult	  population	  
(Freburger	  et	  al.,	  2009).	  It	  accounts	  for	  substantial	  healthcare	  spending	  and	  is	  
considered	  a	  socioeconomic	  burden	  to	  society	  (Katz,	  2006;	  Juniper	  et	  al.,	  2009).	  The	  
	   	   32	  
exact	  mechanisms	  and	  pain	  generators	  contributing	  to	  chronic	  pain	  are	  not	  well	  
understood.	  Moreover,	  up	  to	  85%	  of	  LBP	  cases	  do	  not	  have	  a	  specific	  diagnosis	  and	  
are	  labeled	  as	  “non-­‐specific”,	  which	  results	  in	  lack	  of	  specificity	  in	  treatment	  options	  
(Deyo	  and	  Weinstein,	  2001).	  Spine	  radiographs	  do	  not	  correlate	  with	  clinical	  
features	  of	  pain	  (Jensen,	  Brant-­‐Zawadzki	  et	  al.,	  1994;	  Berg,	  Hellum	  et	  al.,	  2013)	  and	  
play	  a	  limited	  role	  in	  terms	  of	  guiding	  clinical	  practice	  in	  subacute	  and	  chronic	  LBP	  
phases.	  Non-­‐invasive	  neuroimaging	  methods	  can	  be	  used	  to	  gain	  a	  better	  
understanding	  of	  pain	  processing	  and	  associated	  differences	  within	  the	  brain.	  	  
	  
2.B.	  LBP	  and	  Neuroimaging:	  
Recent	  neuroimaging	  studies	  suggest	  the	  involvement	  of	  the	  brain	  in	  chronic	  
LBP.	  We	  have	  previously	  shown	  that	  people	  with	  chronic	  LBP	  have	  decreased	  levels	  
of	  neurochemicals	  (specifically	  N-­‐acetyl	  aspartate)	  in	  sensory	  and	  motor	  cortices	  
that	  correlate	  with	  the	  duration	  and	  intensity	  of	  pain	  (Sharma,	  McCarson	  et	  al.,	  
2011;	  Sharma,	  Brooks	  et	  al.,	  2012).	  Apkarian	  et	  al.	  (2003)	  reported	  similar	  results	  in	  
affective	  brain	  regions,	  dorsolateral	  prefrontal	  cortex	  and	  cingulate	  cortex	  in	  people	  
with	  chronic	  LBP	  (Apkarian,	  Sosa	  et	  al.,	  2004).	  Decrease	  in	  N-­‐acetyl	  aspartate	  can	  be	  
attributed	  to	  neuronal	  degeneration	  of	  metabolic	  changes	  in	  sensory	  and	  affective	  
pain	  regions.	  These	  neuro-­‐metabolic	  changes	  are	  likely	  to	  accompany	  or	  lead	  to	  
volumetric	  differences	  (mainly	  gray	  matter	  volume)	  in	  the	  brain.	  In	  fact,	  a	  number	  
of	  studies	  (a	  total	  of	  7	  studies)	  have	  examined	  brain	  volumetric	  differences	  in	  
people	  with	  chronic	  LBP	  when	  compared	  to	  healthy	  controls.	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Apkarian	  et	  al.	  (2004)	  reported	  significant	  reduction	  of	  global	  brain	  gray	  
matter	  (GM)	  volume	  (5-­‐11%)	  in	  participants	  with	  chronic	  LBP	  as	  compared	  to	  
healthy	  controls.	  They	  attributed	  this	  finding	  to	  be	  equivalent	  to	  GM	  loss	  due	  to	  10-­‐
20	  years	  of	  aging.	  This	  reduction	  was	  significantly	  correlated	  with	  the	  duration	  of	  
pain,	  indicating	  that	  the	  longer	  the	  pain	  duration	  was	  the	  less	  brain	  volume	  
participants	  had	  (Apkarian,	  Sosa	  et	  al.,	  2004).	  Baliki	  et	  al.	  (Baliki,	  Schnitzer	  et	  al.,	  
2011),	  and	  Ivo	  et	  al.	  (Ivo,	  Nicklas	  et	  al.,	  2013)	  reported	  similar	  findings	  in	  relation	  to	  
decreased	  overall	  GM	  volume	  in	  participants	  with	  chronic	  LBP	  when	  compared	  to	  
healthy	  controls.	  On	  the	  other	  hand,	  Schmidte-­‐Wilcke	  et	  al.	  (Schmidt-­‐Wilcke,	  2008),	  
Buckalew	  et	  al.	  (Buckalew	  et	  al.,	  2008),	  Ung	  et	  al.	  (Ung,	  Brown	  et	  al.,	  2014),	  and	  
Dolman	  et	  al.	  (Dolman	  et	  al.,	  2014),	  found	  no	  differences	  in	  GM	  volume	  when	  
comparing	  participants	  with	  chronic	  LBP	  to	  healthy	  controls.	  Mao	  et	  al.	  (2013)	  
examined	  voxel-­‐based	  morphometry	  (VBM)	  in	  people	  with	  LBP	  and	  upper	  back	  
pain.	  They	  reported	  a	  significant	  reduction	  in	  GM	  volume	  in	  multiple	  regions	  related	  
to	  sensory	  and	  affective	  appraisal	  (Mao	  et	  al.,	  2013).	  Although	  some	  of	  these	  studies	  
were	  underpowered	  and	  presented	  inconsistent	  results,	  they	  provide	  initial	  
evidence	  of	  potential	  differences	  in	  brain	  volume.	  A	  better	  understanding	  of	  pain-­‐
specific	  regions	  delineating	  sensory	  versus	  affective	  pain	  regions	  with	  well-­‐powered	  
study	  –	  as	  the	  one	  we	  conducted	  –	  is	  essential	  to	  get	  a	  clear	  understanding	  of	  the	  
extent	  of	  brain	  volumetric	  differences	  in	  LBP.	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3.	  Current	  Gap	  in	  Knowledge	  about	  Subacute	  LBP:	  
Our	  current	  knowledge	  about	  mechanisms	  and	  brain-­‐related	  differences	  in	  
subacute	  LBP	  is	  limited.	  No	  study	  has	  examined	  possible	  central	  nervous	  system	  
differences	  in	  the	  subacute	  phase	  of	  LBP.	  LBP	  can	  become	  chronic	  and	  result	  in	  
decreased	  quality	  of	  life	  and	  eventually	  elevated	  health	  care	  costs	  if	  it	  is	  not	  
managed	  properly.	  People	  experiencing	  pain	  and	  impaired	  function	  at	  6	  weeks	  are	  
less	  likely	  to	  undergo	  recovery	  with	  considerable	  percentage	  progressing	  to	  chronic	  
LBP	  (Waddell,	  1998).	  A	  systematic	  review	  of	  the	  prognosis	  of	  acute	  LBP	  showed	  that	  
pain	  and	  disability	  are	  typically	  ongoing	  and	  73%	  of	  patients	  have	  at	  least	  one	  
recurrence	  of	  LBP	  within	  12	  months	  (Pengel	  et	  al.,	  2003).	  Results	  from	  studies	  
examining	  the	  long-­‐term	  effects	  of	  an	  acute/subacute	  attack	  of	  LBP	  are	  complicated.	  
Most	  of	  the	  time	  studies	  follow-­‐up	  and	  report	  on	  patients	  going	  back	  to	  work	  rather	  
than	  actual	  pain	  scores.	  Return	  to	  work	  does	  not	  necessarily	  indicate	  the	  absence	  of	  
pain;	  therefore	  the	  results	  from	  most	  published	  studies	  are	  thought	  to	  be	  
underestimating	  the	  percentage	  of	  patients	  who	  continue	  to	  have	  LBP	  after	  an	  initial	  
attack	  of	  pain	  (Pengel,	  Herbert	  et	  al.,	  2003).	  	  
	  
During	  the	  transitional	  period	  of	  acute/subacute	  LBP	  into	  chronic	  LBP,	  
recruitment	  of	  additional	  signaling	  mechanisms	  beyond	  acute	  mechanisms	  is	  likely	  
to	  occur.	  Understanding	  these	  differences	  and	  implementing	  targeted	  interventions	  
during	  the	  subacute	  phase	  of	  LBP	  is	  important	  to	  improve	  current	  clinical	  practice	  
and	  reduce	  healthcare	  cost.	  No	  studies	  have	  examined	  the	  transitional	  phase	  of	  LBP	  
from	  a	  brain	  imaging	  perspective,	  whether	  structurally,	  functionally,	  or	  in	  relation	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to	  neurochemistry.	  We	  examined	  brain	  structure	  within	  this	  phase	  in	  this	  study	  and	  
its	  relation	  to	  clinical	  symptoms	  of	  LBP.	  
	  
4.	  Specific	  Aim	  of	  the	  Current	  Study:	  
The	  main	  specific	  aim	  of	  this	  prospective	  study	  was:	  
To	  determine	  the	  relationship	  between	  clinical	  outcome	  measures	  and	  
normalized	  brain	  volumes	  in	  participants	  with	  subacute	  LBP.	  
	  
Hypothesis	  a:	  We	  hypothesize	  that	  whole-­‐brain	  and	  regional	  brain	  volume	  will	  be	  
lower	  in	  the	  subacute	  LBP	  group	  as	  compared	  to	  healthy	  controls.	  	  
	  
Hypothesis	  a:	  We	  hypothesize	  that	  clinical	  outcome	  measures	  of	  pain	  duration,	  pain	  
intensity,	  disability,	  fear	  of	  movement,	  and	  depression	  will	  be	  negatively	  correlated	  
with	  normalized	  whole-­‐brain	  volume.	  
	  
Structural	  brain	  imaging	  measures	  were	  used	  to	  examine	  whole-­‐brain	  and	  regional-­‐
brain	  volumes.	  Standard	  questionnaires	  of	  pain,	  disability,	  fear	  of	  movement,	  and	  
depression	  were	  collected	  and	  correlated	  with	  the	  volumetric	  measurements.	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5.	  Methods	  and	  Analysis:	  
5.A.	  Pilot	  work:	  
In	  2014,	  I	  was	  able	  to	  run	  statistical	  testing	  on	  some	  of	  the	  data	  that	  we	  
collected	  on	  participants	  with	  chronic	  LBP.	  Fourteen	  participants	  (7	  with	  chronic	  
LBP	  and	  7	  healthy	  controls)	  who	  were	  age	  and	  sex	  matched	  were	  included	  in	  the	  
preliminary	  data	  analysis.	  I	  calculated	  the	  normalized	  brain	  volumes	  from	  both	  
groups	  using	  volumetric	  measurements	  and	  then	  used	  the	  VBM	  toolbox	  to	  examine	  
whole-­‐brain	  and	  regional-­‐brain	  differences	  between	  both	  groups.	  The	  preliminary	  
results	  indicated	  some	  structural	  differences	  in	  brain	  volume	  between	  groups	  
(while	  using	  an	  uncorrected	  p	  <	  0.001	  due	  to	  the	  small	  sample	  size).	  Using	  our	  
findings	  we	  submitted	  and	  received	  a	  grant	  from	  the	  Orthopedic	  Section	  of	  the	  
American	  Physical	  Therapy	  Association,	  specifically	  to	  study	  the	  subacute	  
population	  (July	  2015	  –	  June	  2017).	  We	  had	  already	  collected	  data	  on	  17	  
participants	  with	  subacute	  LBP	  in	  our	  lab	  from	  previous	  studies,	  so	  we	  proposed	  to	  
study	  20	  additional	  participants	  with	  subacute	  LBP.	  An	  IRB	  approval	  was	  received	  
in	  October	  2015	  (Appendix	  4)	  and	  data	  collection	  started	  later	  that	  month.	  Our	  main	  
way	  of	  advertising	  was	  broadcast	  e-­‐mails	  to	  all	  university	  staff,	  faculty,	  and	  students	  
and	  electronic	  media	  (mainly	  Craigslist).	  At	  present	  we	  are	  collecting	  data	  towards	  
this	  study.	  Figure	  2.1	  demonstrates	  the	  recruitment	  and	  screening	  process	  of	  this	  
ongoing	  study.	  
	  
After	  completing	  the	  screening	  process	  with	  those	  participants	  only	  6	  
qualified	  and	  agreed	  to	  participate	  in	  our	  study.	  The	  clinical	  data	  and	  brain	  images	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of	  those	  6	  participants	  have	  already	  been	  included	  in	  the	  analysis	  and	  the	  discussion	  
of	  Chapter	  IV.	  We	  will	  continue	  to	  recruit	  participants	  for	  this	  study,	  and	  hope	  to	  
recruit	  all	  20	  by	  the	  end	  of	  year	  2016.	  
	  
5.B.	  Inclusion	  and	  Exclusion	  Criteria:	  
Inclusion	  criteria	  for	  this	  study	  included	  1)	  being	  male	  or	  female	  between	  the	  
ages	  of	  21	  and	  60,	  2)	  having	  LBP	  for	  less	  than	  6	  months,	  and	  3)	  having	  the	  ability	  to	  
read	  and	  write	  English	  (in	  order	  to	  read	  and	  sign	  the	  consent	  form).	  
	  
Exclusion	  criteria	  for	  this	  study	  included	  1)	  having	  spinal	  cord	  compression,	  
tumor,	  or	  infection,	  2)	  any	  neurologic	  conditions	  such	  as	  stroke	  or	  Alzheimer’s	  
Disease,	  3)	  history	  of	  spine	  surgery	  within	  one	  year,	  4)	  head	  trauma,	  psychiatric,	  or	  
cardiovascular	  disease,	  5)	  use	  of	  drugs	  or	  alcohol	  abuse,	  6)	  pregnancy,	  and	  7)	  and	  
MRI	  exclusion	  criteria:	  implanted	  metallic	  objects	  not	  compatible	  with	  MRI,	  
epilepsy,	  claustrophobia	  etc..	  
	  	  
6.	  Results:	  
The	  results	  of	  this	  current	  study	  are	  included	  in	  the	  following	  chapter.	  All	  
demographic,	  clinical,	  and	  brain	  imaging	  data	  for	  the	  subacute	  LBP	  group	  are	  
included	  in	  the	  group	  analysis	  in	  the	  experimental	  chapter	  (Chapter	  IV).	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7.	  Figures:	  
Figure	  2.1:	  Screening	  process	  and	  participant	  recruitment.	  
	  
	  
Anticipated	  a	  total	  of	  20	  participants	  
	  
Contacted	  73	  participants	  
(through	  e-­‐mail)	  
47	  did	  not	  reply	  to	  the	  e-­‐
mail	  we	  sent	  to	  them	  
	  
Screened	  26	  participants	  
(over	  the	  phone)	  
	  
19	  participants	  qualified	  	  
for	  the	  study	  




6	  participants	  recruited	  
for	  the	  study	  
13	  did	  not	  want	  to	  
participate	  or	  did	  not	  
show	  up	  to	  their	  
appointment	  









Brain	  Involvement	  in	  Low	  Back	  Pain	  	  
	   	   40	  
BRAIN	  INVOLVEMENT	  IN	  LOW	  BACK	  PAIN	  	  
	  
Zaid	  M.	  Mansour1,	  MS;	  Rebcca	  J.	  Lepping2,	  PhD;	  Robyn	  A.	  Honea3,	  DPhil;	  
William	  M.	  Brooks2,	  PhD;	  Hung-­‐Wen	  Yeh4,	  PhD;	  Jeffrey	  M.	  Burns3,5,	  MD,	  MS;	  
and	  Neena	  K.	  Sharma1,	  PT,	  PhD	  
1Department	  of	  Physical	  Therapy	  and	  Rehabilitation	  Science,	  University	  of	  Kansas	  
Medical	  Center,	  3901	  Rainbow	  Blvd,	  Kansas	  City,	  Kansas,	  66160	  
2Hoglund	  Brian	  Imaging	  Center,	  University	  of	  Kansas	  Medical	  Center,	  3901	  Rainbow	  
Blvd,	  Kansas	  City,	  Kansas,	  66160	  
3Alzheimer’s	  Research	  Disease	  Center,	  University	  of	  Kansas	  School	  of	  Medicine,	  
Kansas	  City,	  Kansas,	  66160	  
4Department	  of	  Biostatistics,	  University	  of	  Kansas	  Medical	  Center,	  Kansas	  City,	  
Kansas,	  66160	  
5Department	  of	  Neurology,	  University	  of	  Kansas	  School	  of	  Medicine,	  Kansas	  City,	  
Kansas,	  66160	  
	  
Corresponding	  author:	  	   Neena	  K.	  Sharma,	  PT,	  PhD	  
Assistant	  Professor	  	  
Institution:	  	   	   	   University	  of	  Kansas	  Medical	  Center	  	  
	   	   	   	   Rainbow	  Blvd,	  Kansas	  City,	  Kansas,	  66160	  
Phone:	  	   	   	   (913)	  588-­‐4566	  
Fax:	   	   	   	   (913)	  588-­‐4566	  
E-­‐mail:	   	   	   nsharma@kumc.edu	  
	   	   41	  
1.	  Abstract:	  
Low	  back	  pain	  is	  one	  of	  the	  most	  common	  pain	  conditions	  affecting	  millions	  
of	  people	  worldwide.	  Low	  back	  pain	  has	  been	  associated	  with	  less	  brain	  volume	  in	  a	  
few	  studies,	  yet	  this	  finding	  is	  inconsistent	  across	  studies.	  The	  aim	  of	  this	  study	  was	  
to	  determine	  whether	  low	  back	  pain	  (subacute	  and	  chronic)	  is	  related	  to	  brain	  
volume.	  Additionally	  we	  aimed	  to	  examine	  the	  relationship	  between	  brain	  volume	  
and	  clinical	  presentation	  of	  pain.	  A	  total	  of	  130	  participants	  were	  included	  (23	  with	  
subacute	  low	  back	  pain,	  68	  with	  chronic	  low	  back	  pain,	  and	  39	  healthy	  controls).	  
The	  main	  outcome	  measure	  was	  brain	  volume.	  Clinical	  outcome	  measures	  included	  
pain	  duration,	  pain	  intensity,	  fear	  avoidance	  belief	  questionnaire,	  Oswestry	  
disability	  index,	  and	  Beck’s	  depression	  inventory.	  After	  correcting	  for	  multiple	  
comparisons,	  no	  significant	  differences	  were	  detected	  between	  any	  of	  the	  3	  groups	  
in	  whole-­‐brain	  volume.	  However,	  regionally,	  we	  detected	  less	  gray	  matter	  volume	  in	  
2	  voxels	  in	  the	  middle	  frontal	  gyrus	  in	  those	  with	  chronic	  low	  back	  pain	  compared	  
to	  healthy	  controls.	  Without	  correcting	  for	  multiple	  comparisons	  some	  patterns	  of	  
brain	  volume	  differences	  were	  observed.	  None	  of	  the	  clinical	  outcome	  measures	  
were	  correlated	  with	  brain	  volume	  measurements.	  Low	  back	  pain	  (subacute	  or	  
chronic)	  was	  not	  related	  to	  significant	  differences	  in	  brain	  volume.	  The	  effect	  size	  
may	  have	  been	  too	  small	  to	  detect	  possible	  subtle	  changes	  unless	  much	  larger	  
sample	  sizes	  are	  examined,	  or	  it	  is	  also	  possible	  that	  low	  back	  pain	  does	  not	  affect	  
brain	  volume.	  
Keywords:	  low	  back	  pain,	  chronic,	  subacute,	  neuroimaging,	  voxel-­‐based	  
morphometry	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2.	  Introduction:	  
Low	  Back	  Pain	  (LBP)	  is	  one	  of	  the	  most	  common	  pain	  conditions	  affecting	  
millions	  of	  people	  worldwide	  (Flor	  et	  al.,	  1997;	  Von	  Korff	  and	  Dunn,	  2008),	  and	  can	  
be	  a	  major	  cause	  of	  disability	  (Walker	  et	  al.,	  2004;	  Verma	  and	  Pal,	  2015),	  depression	  
(Rush	  et	  al.,	  2000;	  Pincus	  et	  al.,	  2002;	  Ramond	  et	  al.,	  2011),	  and	  loss	  of	  work	  (Rizzo	  
et	  al.,	  1998;	  Nguyen	  and	  Randolph,	  2007).	  Consequently,	  its	  economic	  impacts	  are	  
tremendous	  with	  an	  annual	  cost	  in	  the	  US	  exceeding	  $100	  billion	  (Katz,	  2006).	  One	  
of	  the	  biggest	  mysteries	  of	  LBP	  is	  that	  almost	  85%	  of	  patients	  have	  no	  specific	  
patho-­‐anatomical	  diagnosis	  but	  rather	  have	  idiopathic	  or	  “nonspecific”	  LBP	  (Deyo	  
and	  Weinstein,	  2001).	  Furthermore,	  there	  is	  a	  mismatch	  between	  radiographic	  
findings	  from	  spine	  images	  and	  clinical	  symptoms	  (Berg,	  Hellum	  et	  al.,	  2013;	  Jensen,	  
Srinivasan	  et	  al.,	  2013),	  making	  diagnosing	  -­‐	  and	  even	  understanding	  -­‐	  LBP	  much	  
more	  intricate.	  Although	  underlying	  causes	  of	  LBP	  can	  be	  varied	  and	  difficult	  to	  
determine,	  all	  pain	  sensations	  are	  processed	  similarly	  in	  the	  brain.	  Brain	  imaging	  
methods	  can	  be	  used	  to	  determine	  the	  relationship	  between	  pain	  and	  brain	  function	  
and	  structure.	  	  
	  
Pain	  is	  subjective	  and	  idiosyncratic.	  In	  general,	  the	  pain	  experience	  
incorporates	  two	  main	  components:	  sensory-­‐discriminative	  and	  affective-­‐emotional	  
components.	  These	  components	  are	  processed	  in	  different	  brain	  regions,	  yet	  are	  
integrated	  and	  influenced	  by	  each	  other	  (Borsook,	  Sava	  et	  al.,	  2010).	  Although	  
recent	  evidence	  suggests	  that	  people	  with	  LBP	  have	  altered	  brain	  neurochemistry	  
(Grachev,	  Fredrickson	  et	  al.,	  2000;	  Sharma,	  Brooks	  et	  al.,	  2012)	  and	  function	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(Giesecke,	  Gracely	  et	  al.,	  2004;	  Tagliazucchi,	  Balenzuela	  et	  al.,	  2010),	  similar	  
structural	  brain	  changes	  have	  not	  been	  established.	  	  
	  
Smaller	  brain	  volumes	  have	  been	  reported	  in	  such	  neurodegenerative	  
diseases	  as	  multiple	  sclerosis	  (Cheriyan	  et	  al.,	  2012;	  Koenig	  et	  al.,	  2014;	  Radue	  et	  al.,	  
2015),	  Alzheimer’s	  disease	  (Karas	  et	  al.,	  2004;	  Ibrahim	  et	  al.,	  2009;	  Gordon	  et	  al.,	  
2013),	  and	  schizophrenia	  (Shenton	  et	  al.,	  2001;	  Cahn	  et	  al.,	  2002;	  Kasparek	  et	  al.,	  
2009),	  and	  also	  in	  chronic	  pain	  conditions	  such	  as	  fibromyalgia	  (Kuchinad	  et	  al.,	  
2007;	  Diaz-­‐Piedra	  et	  al.,	  2015;	  McCrae	  et	  al.,	  2015),	  complex	  regional-­‐pain	  
syndrome	  (Geha,	  Baliki	  et	  al.,	  2008;	  Barad	  et	  al.,	  2014),	  and	  chronic	  LBP	  (Apkarian,	  
Sosa	  et	  al.,	  2004;	  Baliki,	  Schnitzer	  et	  al.,	  2011).	  To	  date,	  seven	  structural	  brain	  
imaging	  studies	  examining	  volumetric	  brain	  measurements	  in	  people	  with	  chronic	  
LBP	  (Apkarian,	  Sosa	  et	  al.,	  2004;	  Schmidt-­‐Wilcke	  et	  al.,	  2006;	  Buckalew,	  Haut	  et	  al.,	  
2008;	  Baliki,	  Schnitzer	  et	  al.,	  2011;	  Ivo,	  Nicklas	  et	  al.,	  2013;	  Dolman,	  Loggia	  et	  al.,	  
2014;	  Ung,	  Brown	  et	  al.,	  2014)	  have	  been	  completed.	  Findings	  from	  these	  studies	  
were	  inconsistent,	  with	  some	  observing	  smaller	  volumes	  in	  participants	  with	  
chronic	  LBP	  compared	  to	  healthy	  controls,	  and	  others	  finding	  no	  group	  differences	  
in	  brain	  volume.	  Importantly,	  the	  sample	  sizes	  in	  these	  studies	  were	  modest	  and	  
many	  of	  those	  that	  reported	  differences	  in	  brain	  volume	  based	  their	  conclusions	  on	  
results	  uncorrected	  for	  multiple	  comparisons	  (Schmidt-­‐Wilcke,	  Leinisch	  et	  al.,	  2006;	  
Buckalew,	  Haut	  et	  al.,	  2008;	  Ivo,	  Nicklas	  et	  al.,	  2013),	  drawing	  into	  question	  the	  
significance	  of	  the	  observation.	  Moreover,	  no	  studies	  have	  addressed	  subacute	  LBP	  
in	  terms	  of	  brain	  structure	  and	  whether	  such	  potential	  differences	  exist	  during	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earlier	  stages	  of	  the	  disease.	  The	  relationship	  between	  possible	  volumetric	  
differences	  and	  clinical	  presentation	  of	  LBP	  is	  also	  unclear.	  	  
	  
The	  main	  aims	  of	  this	  study	  were	  to	  determine	  whether	  there	  are:	  1)	  whole-­‐
brain	  volumetric	  differences	  in	  participants	  with	  subacute	  and	  chronic	  LBP	  
compared	  to	  healthy	  controls,	  within	  a	  relatively	  large	  sample,	  measured	  by	  total	  
volume	  measurements	  and	  voxel-­‐based	  morphometry	  (VBM);	  2)	  regional	  brain	  
differences	  in	  participants	  with	  subacute	  and	  chronic	  LBP	  compared	  to	  healthy	  
controls	  measured	  by	  VBM;	  and	  3)	  relationships	  between	  clinical	  outcome	  measures	  
and	  brain	  volumes	  in	  participants	  with	  subacute	  and	  chronic	  LBP.	  We	  hypothesized	  
that	  participants	  with	  chronic	  LBP	  would	  have	  smaller	  whole-­‐brain	  volumes	  as	  
compared	  to	  subacute	  and	  healthy	  controls,	  and	  participants	  with	  subacute	  LBP	  
would	  have	  smaller	  whole-­‐brain	  volumes	  compared	  to	  healthy	  controls.	  Secondly,	  
we	  hypothesized	  that	  we	  would	  find	  smaller	  brain	  volumes	  within	  sensory	  and	  
affective	  pain	  processing	  regions	  in	  participants	  with	  LBP.	  Finally,	  we	  hypothesized	  
a	  negative	  correlation	  between	  normalized	  whole-­‐brain	  volumes	  and	  clinical	  
outcome	  measures	  such	  as	  pain	  intensity,	  pain	  duration,	  depression,	  or	  fear	  
avoidance.	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3.	  Methods:	  
3.A.	  Study	  Population:	  
130	  participants	  were	  included	  in	  this	  study:	  subacute	  (<6	  months)	  LBP	  
(n=23,	  57%	  female),	  chronic	  (>6	  months)	  LBP	  (n=68,	  71%	  female),	  and	  healthy	  
controls	  (n=39	  participants,	  44%	  female).	  Inclusion	  criteria	  for	  the	  LBP	  participants	  
were:	  1)	  male/female	  between	  21	  and	  70	  years,	  2)	  having	  pain	  for	  less	  than	  6	  
months	  (subacute	  group)	  and	  more	  than	  6	  moths	  (chronic	  group),	  and	  3)	  being	  able	  
to	  read	  and	  understand	  English.	  Exclusion	  criteria	  were:	  1)	  spinal	  cord	  compression	  
or	  spine	  surgery	  within	  the	  past	  year,	  2)	  known	  injuries	  or	  arthritis	  to	  the	  hip,	  knee	  
or	  ankle	  joints,	  3)	  any	  neurologic	  condition	  (including	  head	  trauma,	  stroke,	  or	  
Alzheimer’s	  disease),	  4)	  psychiatric	  or	  cardiovascular	  disease,	  tumor,	  or	  infection,	  5)	  
use	  of	  drugs	  or	  alcohol	  abuse,	  6)	  pregnancy,	  and	  7)	  MRI	  exclusion	  criteria	  (such	  as	  
metallic	  object	  implants	  not	  compatible	  with	  MRI,	  epilepsy,	  or	  claustrophobia).	  The	  
healthy	  controls	  self-­‐reported	  no	  history	  of	  LBP	  within	  the	  last	  one	  year.	  
Participants	  were	  recruited	  through	  broadcast	  e-­‐mails	  to	  university	  staff	  and	  
employees,	  and	  word-­‐of-­‐mouth.	  The	  study	  was	  approved	  by	  the	  Human	  Subject	  
Committee	  at	  the	  University	  of	  Kansas	  Medical	  Center,	  and	  all	  participants	  provided	  
informed	  consent	  prior	  to	  taking	  part	  in	  the	  study.	  
	  
3.B.	  Imaging	  Procedures:	  	  
High-­‐resolution	  T1-­‐weighted	  magnetization	  prepared	  rapid	  acquisition	  
gradient	  echo	  (MP-­‐RAGE)	  brain	  images	  were	  collected	  at	  3-­‐Tesla	  (matrix=256x256;	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208	  slices;	  voxels=1.0	  mm	  x	  1	  mm	  x	  0.97	  mm;	  TE=3.05	  ms;	  and	  TR=2300	  ms	  on	  
Siemens	  Allegra	  and	  Skyra,	  Siemens	  Medical	  Solutions,	  Germany)	  at	  the	  University	  
of	  Kansas	  Medical	  Center	  Hoglund	  Brain	  Imaging	  Center.	  Standard	  preprocessing	  
was	  performed	  for	  all	  images	  using	  VBM8	  toolbox(Ashburner	  and	  Friston,	  2000)	  
through	  Statistical	  Parametric	  Mapping	  software	  SPM8	  (Welcome	  Department	  of	  
Cognitive	  Neurology,	  London,	  UK)	  that	  operates	  under	  MATLAB	  (Mathworks,	  
Sherborn,	  MA,	  USA).	  Preprocessing	  included	  spatial	  normalization	  of	  all	  acquired	  
images	  into	  the	  same	  stereotactic	  space,	  to	  account	  for	  head	  size	  differences	  
between	  participants.	  DARTEL	  segmentation	  into	  gray	  matter	  (GM),	  white	  matter	  
(WM),	  and	  cerebrospinal	  fluid	  (CSF),	  and	  Gaussian	  spatial	  smoothing	  (8	  mm	  full-­‐
width	  at	  half-­‐maximum)	  as	  determined	  by	  previous	  studies	  was	  performed.	  Image	  
quality	  and	  sample	  homogeneity	  were	  verified	  through	  visual	  inspection	  using	  the	  
VBM8	  tools	  (Ashburner	  and	  Friston,	  2000).	  We	  used	  volumetric	  outputs	  from	  the	  
VBM8	  stream	  to	  calculate	  individual	  normalized	  whole-­‐brain	  volume,	  which	  is	  the	  
sum	  of	  GM	  volume	  and	  WM	  volume	  divided	  by	  total	  intracranial	  volume.	  Further,	  
we	  used	  VBM	  analysis	  to	  generate	  smoothed,	  modulated,	  warped	  statistical	  brain	  
maps	  of	  the	  probability	  of	  difference	  in	  brain	  volume	  between	  groups	  of	  
participants	  (Ashburner	  and	  Friston,	  2000).	  
	  
For	  region-­‐of-­‐interest	  (ROI)	  analysis	  we	  used	  the	  Wake-­‐Forest	  PickAtlas	  
(Maldjian	  et	  al.,	  2003;	  Maldjian	  et	  al.,	  2004)	  to	  create	  masks	  of	  pain-­‐related	  brain	  
regions	  (Borsook,	  Sava	  et	  al.,	  2010).	  Four	  ROI	  masks	  were	  created;	  a	  sensory	  mask,	  
which	  included	  the	  primary	  somatosensory	  cortex	  and	  the	  posterior	  insula;	  a	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cortical	  affective	  mask	  which	  included	  the	  cingulate,	  orbitofrontal,	  and	  medial	  
prefrontal	  cortices	  and	  the	  anterior	  insula;	  a	  subcortical	  affective	  mask	  which	  
included	  nucleus	  accumbens,	  amygdala,	  caudate,	  and	  hippocampus;	  and	  a	  mask	  of	  
the	  thalamus.	  The	  thalamus	  was	  created	  as	  a	  separate	  mask,	  as	  both	  sensory	  and	  
affective	  pain	  experiences	  are	  processed	  via	  thalamus	  (Borsook,	  Sava	  et	  al.,	  2010).	  
	  
3.C.	  Clinical	  Outcome	  Measures:	  
The	  clinical	  outcome	  measures	  included	  pain	  duration,	  pain	  intensity,	  fear	  
avoidance,	  disability,	  and	  depression.	  Pain	  duration	  was	  measured	  in	  months.	  Pain	  
intensity	  was	  measured	  as	  the	  subjective	  rating	  of	  pain	  severity	  over	  the	  previous	  
week	  measured	  by	  the	  Numeric	  Rating	  Scale	  (NRS)	  (Chapman,	  Norvell	  et	  al.,	  2011).	  
The	  NRS	  is	  a	  0-­‐10	  scale	  that	  represents	  pain	  level,	  with	  0	  as	  having	  no	  pain	  and	  10	  
as	  having	  the	  worst	  pain	  imaginable.	  Fear	  avoidance	  was	  measured	  by	  the	  Fear	  
Avoidance	  Belief	  Questionnaire	  (FABQ),	  which	  quantifies	  the	  subjective	  impact	  of	  
work	  and	  physical	  activity	  on	  pain	  level	  (Waddell,	  Newton	  et	  al.,	  1993).	  This	  
instrument	  is	  a	  16-­‐item	  questionnaire	  with	  each	  item	  scored	  from	  0-­‐6.	  Higher	  
scores	  indicate	  higher	  levels	  of	  fear	  avoidance.	  Disability	  was	  measured	  by	  the	  
Oswestry	  Disability	  Index	  (ODI	  (Fairbank,	  Couper	  et	  al.,	  1980)),	  which	  quantifies	  
individual	  disability	  due	  to	  LBP.	  ODI	  scores	  greater	  than	  60%	  indicate	  severe	  
disability	  (Fairbank	  and	  Pynsent,	  2000;	  Joshi,	  Raiturker	  et	  al.,	  2013;	  Mohan	  et	  al.,	  
2015).	  Finally,	  depression	  symptoms	  were	  measured	  using	  the	  Beck	  Depression	  
Inventory	  (BDI–II),	  which	  has	  been	  validated	  in	  multiple	  studies	  (Wang	  and	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Gorenstein,	  2013).	  BDI–II	  scores	  greater	  than	  17	  indicate	  borderline	  depressive	  
symptoms.	  
	  
3.D.	  Statistical	  Analysis:	  
To	  investigate	  difference	  in	  age	  between	  the	  groups,	  we	  conducted	  an	  
analysis-­‐of-­‐variance	  (ANOVA)	  test,	  followed	  by	  Tukey’s	  post-­‐hoc	  testing	  using	  SPSS	  
22.0	  software	  (IBM	  Corp.	  Released	  2013.	  IBM	  SPSS	  Statistics	  for	  Macintosh,	  Version	  
22.0.	  Armonk,	  NY:	  IBM	  Corp). Then,	  we	  conducted	  Chi-­‐square	  testing	  to	  investigate	  
differences	  in	  sex	  and	  scanner	  between	  groups.	  	  Age,	  sex,	  and	  scanner	  difference	  
were	  then	  used	  as	  covariates	  in	  each	  of	  the	  brain	  volume	  analyses.	   
	  
• Normalized	  Whole-­‐Brain	  Volumes:	  
To	  determine	  whether	  there	  were	  overall	  brain	  volume	  differences	  between	  the	  
three	  groups,	  we	  conducted	  a	  univariate	  one-­‐way	  ANOVA	  test	  using	  SPSS	  for	  the	  
normalized	  whole-­‐brain	  volumes	  as	  the	  dependent	  variable,	  and	  group	  (subacute,	  
chronic,	  healthy)	  as	  the	  independent	  variable	  controlling	  for	  age,	  sex,	  and	  scanner	  as	  
covariates.	  	  
	  
• Voxel-­‐Based	  Analysis	  (whole-­‐brain	  and	  ROI):	  
We	  examined	  GM	  volume	  differences	  between	  the	  groups	  using	  SPM8.	  We	  
conducted	  two	  sample	  t-­‐tests	  between	  each	  pair	  of	  groups	  (healthy-­‐subacute,	  
healthy-­‐chronic,	  subacute-­‐chronic)	  over	  the	  whole	  brain	  and	  then	  within	  the	  four	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regional	  masks,	  correcting	  for	  multiple	  comparisons	  in	  each	  test.	  Age,	  sex,	  and	  
scanner	  were	  controlled	  for	  in	  each	  test.	  
	  
• Correlation	  Analysis: 
In	  order	  to	  detect	  relationships	  between	  clinical	  outcome	  measures	  and	  brain	  
volume,	  we	  conducted	  partial	  correlations	  between	  the	  normalized	  whole-­‐brain	  
volumes	  and	  each	  clinical	  outcome	  measure	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  
separately	  using	  SPSS	  22.0	  software,	  while	  controlling	  for	  age,	  sex,	  and	  scanner	  in	  
each	  test. 
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4.	  Results:	  
The	  ANOVA	  test	  revealed	  a	  significant	  age	  difference	  between	  the	  groups	  
(F(2,127)=3.99,	  p=0.021,	  η2=0.06),	  with	  the	  chronic	  group	  being	  significantly	  older	  
than	  the	  subacute	  group	  (p=0.025,	  Mdifference	  =-­‐8.39,	  std.	  error=3.18)	  and	  no	  difference	  
between	  the	  healthy	  and	  subacute	  (p=0.527,	  Mdifference=3.74,	  std.	  error=3.46)	  or	  
healthy	  and	  chronic	  groups	  (p=0.189,	  Mdifference	  =-­‐4.64,	  std.	  error=2.65).	  The	  Chi-­‐
square	  test	  showed	  that	  the	  ratio	  of	  males/females	  was	  different	  across	  the	  groups	  
(𝜒!(2)=7.67,	  p=0.022)	  with	  a	  greater	  proportion	  of	  females	  in	  the	  chronic	  LBP	  
group.	  The	  ratio	  of	  participants	  scanned	  on	  the	  two	  scanners	  was	  not	  significantly	  
different	  across	  groups	  (𝜒!(2)=5.40,	  p=0.067)	  with	  more	  participants	  scanned	  on	  
the	  Allegra	  scanner	  in	  all	  3	  groups	  (healthy	  84.6%,	  subacute	  60.8%,	  and	  chronic	  
66.2%).	  Therefore,	  throughout	  this	  study	  we	  included	  age,	  sex,	  and	  scanner	  as	  
covariates	  in	  our	  analyses.	  	  
	  
4.A.	  Clinical	  Features:	  
Demographic	  and	  clinical	  data	  are	  presented	  in	  Table	  3.1.	  The	  clinical	  
outcomes	  were	  collected	  only	  from	  participants	  with	  LBP	  (subacute	  and	  chronic).	  
There	  was	  no	  statistical	  difference	  between	  both	  LBP	  groups	  in	  any	  of	  the	  outcome	  
measures	  except	  for	  pain	  duration	  and	  disability	  scores.	  Participants	  in	  the	  chronic	  
LBP	  group	  had	  experienced	  pain	  longer	  than	  the	  subacute	  LBP	  group	  (t(86)=-­‐5.63,	  
p<0.001).	  Moreover,	  the	  same	  group	  showed	  greater	  levels	  of	  disability	  compared	  to	  
the	  subacute	  LBP	  group	  (t(87)=-­‐2.47,	  p=0.016).	  	  
	   	   51	  
4.B.	  Brain	  Volume	  Differences:	  
• Normalized	  Whole-­‐Brain	  Volumes:	  
There	  was	  no	  overall	  difference	  in	  normalized	  whole-­‐brain	  volume	  between	  groups	  
after	  controlling	  for	  age,	  sex,	  and	  scanner	  (F(2,124)=1.63,	  p=0.20,	  η2=0.03).	  Figure	  
3.1	  presents	  the	  mean	  and	  standard	  deviation	  of	  the	  normalized	  whole-­‐brain	  
volumes	  for	  each	  group.	  Additionally	  we	  determined	  the	  effect	  size	  of	  this	  aim	  using	  
G-­‐Power	  software	  (Faul	  et	  al.,	  2007;	  Faul	  et	  al.,	  2009).	  Through	  calculating	  the	  
means	  and	  standard	  deviations	  of	  the	  normalized	  whole-­‐brain	  volumes	  for	  each	  of	  
our	  groups	  we	  detected	  an	  effect	  size	  of	  0.07,	  which	  is	  considered	  a	  small	  effect	  size.	  
We	  then	  calculated	  the	  sample	  size	  required	  to	  detect	  this	  effect	  size	  (0.07)	  at	  a	  
power	  of	  80%	  and	  it	  was	  a	  total	  of	  1722	  participants.	  
	  
• Voxel-­‐Based	  Analysis	  (whole-­‐brain	  and	  ROI):	  
Following	  correction	  for	  multiple	  comparisons	  (family-­‐wise	  error	  corrected	  
p<0.05),	  we	  found	  no	  differences	  between	  any	  inter-­‐group	  comparisons	  on	  the	  
whole-­‐brain	  level.	  All	  comparisons	  tested	  both	  contrasts	  of	  each	  set	  (for	  example,	  
subacute>healthy	  and	  healthy>subacute).	  However,	  to	  verify	  whether	  previously	  
reported	  trends	  were	  also	  observed	  in	  this	  large	  sample,	  we	  repeated	  the	  
comparisons	  using	  uncorrected	  p<0.001	  and	  a	  threshold	  of	  100	  contiguous	  voxels.	  
At	  this	  less	  stringent	  threshold	  we	  observed	  evidence	  of	  volume	  differences	  in	  some	  
regions:	  middle	  frontal	  gyrus,	  superior	  frontal	  gyrus,	  parahippocampal	  gyrus,	  and	  
cerebellum	  (Table	  3.2).	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The	  ROI	  analysis	  of	  the	  cortical	  affective	  mask	  indicated	  that	  the	  chronic	  LBP	  
group	  have	  less	  GM	  volume	  in	  2	  voxels	  (6.75	  mm3)	  within	  the	  middle	  frontal	  gyrus	  
(MNI-­‐coordinates:	  	  	  -­‐34/51/15)	  compared	  with	  healthy	  controls	  (corrected	  p<0.05;	  
Figure	  3.2).	  No	  other	  ROI	  comparisons	  showed	  any	  differences	  in	  GM	  volume.	  	  
	  
• Correlation	  Analysis: 
The	  clinical	  outcome	  measures	  were	  not	  correlated	  with	  the	  normalized	  whole-­‐
brain	  volumes	  in	  either	  subacute	  or	  chronic	  LBP	  groups	  after	  controlling	  for	  age,	  
sex,	  and	  scanner	  (all	  r<0.18	  Table	  3.3).	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5.	  Discussion: 
To	  our	  knowledge	  this	  is	  the	  largest	  study	  (total	  of	  130	  participants)	  that	  has	  
examined	  brain	  volume	  in	  participants	  with	  LBP.	  Although	  several	  studies	  have	  
investigated	  chronic	  LBP,	  none	  have	  addressed	  the	  subacute	  population.	  This	  is	  the	  
first	  to	  examine	  such	  brain	  volume	  effects	  within	  the	  subacute	  LBP	  population.	  
	  
Our	  results	  are	  consistent	  with	  previous	  reports	  that	  found	  no	  difference	  in	  
whole-­‐brain	  volumes	  in	  chronic	  LBP	  (Schmidt-­‐Wilcke,	  Leinisch	  et	  al.,	  2006;	  
Buckalew,	  Haut	  et	  al.,	  2008;	  Dolman,	  Loggia	  et	  al.,	  2014;	  Ung,	  Brown	  et	  al.,	  2014),	  
and	  suggest	  that	  chronic	  LBP	  is	  not	  associated	  with	  robust	  differences	  in	  brain	  
structure	  and	  volume.	  Consistent	  with	  this	  theoretical	  argument,	  we	  also	  found	  no	  
difference	  in	  brain	  volume	  in	  participants	  in	  the	  earlier	  (subacute)	  stages	  of	  the	  
disease.	  Additionally,	  when	  examining	  sensory	  and	  affective	  pain-­‐related	  ROIs	  we	  
found	  evidence	  of	  lower	  middle	  frontal	  gyral	  (cortical	  affective	  mask)	  volume	  in	  2	  
voxels	  in	  participants	  with	  chronic	  LBP	  compared	  to	  healthy	  controls.	  If	  structural	  
brain	  changes	  were	  occurring	  during	  persistent	  LBP,	  they	  must	  therefore	  be	  very	  
subtle	  and	  would	  require	  a	  very	  large	  sample	  size	  (about	  1700	  subjects)	  to	  detect	  
with	  current	  structural	  brain	  imaging	  techniques.	  Dolman	  et	  al.	  reported	  needing	  up	  
to	  1616	  participants	  per	  group	  to	  detect	  such	  differences	  in	  the	  chronic	  LBP	  
population	  (Dolman,	  Loggia	  et	  al.,	  2014).	  
	  
We	  conducted	  partial	  correlations	  (controlling	  for	  age,	  sex,	  and	  scanner)	  and	  
did	  not	  find	  any	  correlation	  between	  clinical	  measures	  and	  normalized	  whole-­‐brain	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volume.	  These	  findings	  did	  not	  support	  our	  original	  hypothesis.	  Although	  within	  the	  
broad	  pain	  literature,	  findings	  suggest	  a	  correlation	  between	  clinical	  outcome	  
measures	  and	  brain	  volume	  (Kuchinad,	  Schweinhardt	  et	  al.,	  2007;	  Kim	  et	  al.,	  2008;	  
Blankstein	  et	  al.,	  2010),	  studies	  specifically	  examining	  LBP	  reported	  no	  correlations	  
between	  such	  outcomes	  and	  brain	  volume	  even	  in	  the	  presence	  of	  brain	  volume	  
differences	  (Baliki,	  Schnitzer	  et	  al.,	  2011;	  Ivo,	  Nicklas	  et	  al.,	  2013).	  Such	  findings	  
question	  the	  clinical	  relevance	  of	  the	  differences	  in	  brain	  volume	  reported	  in	  
previous	  pilot	  studies.	  	  
	  
Brain	  imaging	  results	  can	  be	  influenced	  by	  many	  factors.	  We	  employed	  
rigorous	  methods	  to	  avoid	  type	  1	  errors.	  We	  corrected	  for	  multiple	  comparisons	  as	  
recommended	  by	  the	  creators	  of	  VBM	  (Ashburner	  and	  Friston,	  2000).	  Other	  studies	  
either	  did	  not	  correct	  for	  multiple	  comparisons	  (Schmidt-­‐Wilcke,	  Leinisch	  et	  al.,	  
2006;	  Buckalew,	  Haut	  et	  al.,	  2008;	  Ivo,	  Nicklas	  et	  al.,	  2013)	  or	  used	  a	  different	  
method	  (such	  as	  permutation	  testing	  (Apkarian,	  Sosa	  et	  al.,	  2004)).	  Another	  
difference	  is	  related	  to	  the	  methodology	  and	  subject	  recruitment.	  We	  recruited	  
participants	  with	  LBP	  and	  then	  healthy	  controls	  and	  conducted	  ANOVA,	  controlled	  
for	  age	  and	  sex,	  to	  compare	  our	  groups	  as	  suggested	  by	  Dolman	  et	  al.	  (Dolman,	  
Loggia	  et	  al.,	  2014)	  We	  also	  used	  two-­‐sample	  t-­‐tests,	  unlike	  some	  of	  the	  
methodology	  used	  by	  other	  researchers.	  The	  latest	  study	  published	  on	  this	  topic	  by	  
Dolman	  et	  al.	  concluded	  that	  controlling	  for	  the	  main	  covariates	  (such	  as	  age	  and	  
pain	  levels)	  could	  reduce	  -­‐	  or	  even	  potentially	  eliminate	  -­‐	  the	  previously	  reported	  
findings	  of	  differences	  in	  brain	  volume	  (Dolman,	  Loggia	  et	  al.,	  2014).	  Mover,	  it	  is	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well	  known	  that	  aging	  is	  associated	  with	  decreases	  in	  GM	  and	  WM	  volumes	  (Good	  et	  
al.,	  2001).	  This	  loss	  is	  not	  homogeneously	  distributed	  across	  the	  brain,	  with	  some	  
regions	  demonstrating	  more	  decline	  in	  GM	  volume	  with	  aging	  than	  others.	  This	  
includes	  regions	  that	  are	  related	  to	  pain	  processing	  such	  as	  the	  orbitofrontal,	  
cingulate,	  and	  insular	  cortices	  (Resnick	  et	  al.,	  2003)	  that	  might	  explain	  our	  failure	  to	  
detect	  volume	  differences	  after	  we	  carefully	  controlled	  for	  age	  effects.	  	  
	  
Several	  theoretical	  models	  have	  been	  proposed	  as	  mechanisms	  for	  brain	  
volume	  changes	  in	  chronic	  LBP;	  however,	  these	  models	  account	  for	  both	  theoretical	  
decreases	  and	  increases	  in	  brain	  volume,	  making	  interpretation	  of	  brain	  volumes	  
from	  MR	  images	  difficult.	  Increased	  levels	  of	  glutamate	  have	  been	  reported	  in	  
chronic	  pain	  (Mullins	  et	  al.,	  2005;	  Harris	  et	  al.,	  2009;	  Valdes	  et	  al.,	  2010;	  Gerstner	  et	  
al.,	  2012;	  Fayed	  et	  al.,	  2014).	  Prolonged	  exposure	  to	  high	  levels	  of	  glutamate	  is	  
neurotoxic,	  and	  this	  neurotoxicity	  could	  result	  in	  loss	  of	  neurons	  via	  
neurodegeneration	  or	  neuronal	  apoptosis	  (Rothstein,	  1996).	  Conversely,	  some	  have	  
argued	  that	  increased	  glutamate	  might	  lead	  to	  tissue	  scarring	  and	  therefore	  
increasing	  cortical	  thickness	  (Dolman,	  Loggia	  et	  al.,	  2014).	  Moreover,	  after	  tissue	  
injury	  cells	  hypertrophy	  in	  response	  to	  increased	  levels	  of	  glutamate	  (Buffo	  et	  al.,	  
2008),	  potentially	  reversing	  cell	  volume	  loss.	  In	  addition	  to	  neurochemical	  
hypotheses,	  some	  researchers	  credit	  volumetric	  differences	  to	  changes	  in	  lifestyle,	  
since	  chronic	  pain	  leads	  to	  decreased	  mobility	  and	  activity	  (Tracey	  and	  Mantyh,	  
2007).	  Exercise	  has	  been	  shown	  to	  assist	  in	  increasing	  brain	  volume	  (Gondoh	  et	  al.,	  
2009;	  Erickson	  et	  al.,	  2011),	  suggesting	  that	  less	  mobility	  might	  be	  related	  to	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decreased	  brain	  volume.	  More	  research	  is	  needed	  to	  confirm	  or	  refute	  these	  
theories.	  
	  
Our	  results	  suggest	  that	  brain	  volume	  is	  not	  severely	  affected	  by	  LBP,	  with	  
other	  factors	  (such	  as	  age)	  having	  a	  larger	  impact	  on	  brain	  volume.	  Nonetheless,	  the	  
brain	  cytoarchitecture	  might	  be	  affected	  by	  pain.	  Such	  differences	  require	  other	  
methods	  of	  detection.	  For	  example,	  this	  might	  explain	  why	  other	  studies	  (Grachev,	  
Fredrickson	  et	  al.,	  2000;	  Giesecke,	  Gracely	  et	  al.,	  2004;	  Kobayashi,	  Kurata	  et	  al.,	  
2009;	  Tagliazucchi,	  Balenzuela	  et	  al.,	  2010;	  Gussew,	  Rzanny	  et	  al.,	  2011;	  
Boendermaker	  et	  al.,	  2014)	  (including	  those	  conducted	  in	  our	  laboratory	  (Sharma,	  
McCarson	  et	  al.,	  2011;	  Sharma,	  Brooks	  et	  al.,	  2012))	  have	  observed	  differences	  in	  
brain	  function	  and	  neurochemistry	  in	  people	  with	  chronic	  LBP	  and	  yet	  we	  did	  not	  
detect	  gross	  structural	  differences	  with	  VBM.	  	  It	  may	  also	  be	  possible	  that	  LBP	  
people	  with	  higher	  pain	  intensity	  than	  reported	  by	  our	  cohort	  and	  greater	  level	  of	  
depression	  and	  disability	  may	  have	  greater	  effect	  on	  brain	  structure.	  Our	  subject	  
experienced	  moderate	  pain	  intensity	  and	  minimum	  depression	  and	  disability.	  	  
	  
Although	  we	  used	  a	  large	  sample	  size	  and	  stringent	  data	  analysis	  methods	  
available	  we	  acknowledge	  some	  limitations.	  First,	  there	  was	  a	  significant	  difference	  
in	  age	  between	  groups.	  This	  was	  anticipated	  since	  our	  LBP	  groups	  are	  defined	  by	  
duration	  of	  their	  pain,	  and	  hence	  we	  expected	  the	  chronic	  group	  to	  have	  older	  
participants	  than	  those	  in	  the	  subacute	  group.	  Also,	  there	  was	  a	  significant	  
difference	  in	  sex	  proportion	  within	  our	  sample.	  Again	  this	  was	  also	  anticipated	  since	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chronic	  pain	  is	  more	  prevalent	  in	  females	  than	  males	  (Mogil,	  2012).	  Finally,	  
although	  we	  collected	  data	  on	  different	  scanners,	  all	  acquisition	  parameters	  were	  
identical.	  Moreover,	  since	  we	  are	  comparing	  calculated	  volumes	  that	  are	  based	  on	  
careful	  scanner	  calibrations	  completed	  during	  routine	  quality	  assurance	  
procedures,	  this	  is	  unlikely	  to	  contribute	  to	  false	  findings.	  Nonetheless,	  we	  added	  
each	  of	  these	  factors	  as	  a	  covariate	  in	  our	  analyses	  to	  minimize	  their	  potential	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6.	  Conclusion:	  
Clinical	  interpretation	  of	  this	  line	  of	  research	  can	  be	  challenging.	  However,	  
we	  conclude	  that	  there	  is	  a	  minimum-­‐	  to	  no-­‐effect	  of	  LBP	  (subacute	  or	  chronic)	  on	  
brain	  volume	  and	  structure.	  LBP	  might	  have	  effects	  on	  brain	  function	  and	  brain	  
neurochemistry.	  However,	  our	  study	  did	  not	  find	  any	  significant	  differences	  in	  brain	  
volume	  after	  controlling	  for	  age,	  sex,	  and	  scanner	  differences,	  and	  after	  correcting	  
for	  multiple	  comparisons	  in	  participants	  with	  LBP	  (subacute	  and	  chronic)	  as	  
compared	  to	  healthy	  controls.	  Moreover,	  none	  of	  the	  clinical	  outcome	  measures	  that	  
we	  collected	  showed	  any	  significant	  correlation	  with	  brain	  volumes.	  Our	  findings	  
can	  be	  calming	  to	  physicians,	  therapists,	  and	  even	  patients	  given	  the	  alarming	  
findings	  of	  the	  first	  study	  in	  this	  field	  (Apkarian,	  Sosa	  et	  al.,	  2004)	  that	  suggested	  
participants	  with	  chronic	  LBP	  had	  a	  5-­‐11%	  decrease	  in	  GM	  volume.	  Also	  researchers	  
can	  expand	  this	  field	  of	  research	  by	  examining	  the	  brain	  using	  different	  imaging	  
modalities	  like	  functional	  MRI,	  magnetic	  resonance	  spectroscopy,	  or	  even	  diffusion	  
tensor	  imaging.	  Structural	  brain	  imaging,	  provide	  insights	  into	  brain	  volume;	  
however,	  it	  cannot	  inform	  researchers	  about	  any	  of	  the	  cyto-­‐architectural	  
differences	  of	  brain	  tissue	  that	  may	  occur	  when	  comparing	  people	  with	  LBP	  to	  
healthy	  controls.	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9.	  Figures:	  
Figure	  3.1:	  Normalized	  whole-­‐brain	  volumes	  for	  each	  group	  
	  
HC:	  Healthy	  controls,	  sLBP:	  subacute	  low	  back	  pain	  group,	  cLBP:	  chronic	  low	  back	  
pain	  group,	  NWBV:	  normalized	  whole-­‐brain	  volume.	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Figure	  3.2:	  Cortical	  affective	  mask	  and	  the	  presentation	  of	  chronic	  LBP	  participants	  
showing	  less	  GM	  volume	  within	  that	  mask.	  
	   	  
	   	   3.2	  a	   	   	   	   	   	  	  	  	  	  3.2	  b	  	  	  
3.2	  a:	  Cortical	  affective	  mask,	  3.2	  b:	  Affective	  cortical	  ROI,	  pcorrected	  <	  0.05.	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10.	  Tables:	  
Table	  3.1:	  Demographic	  and	  clinical	  outcome	  measures.	  
	  
Characteristic	   sLBP	   cLBP	   HC	   Statistic	   p	  
Sex	  
(Female/Male)†	  
13/10	   48/20	   17/22	   χ2=7.67	   0.022*	  
Age	  ‡	   36±11	   45±12	   40±16	   F=3.99	   0.021*	  
Pain	  Duration	  §	   3.16±2.17	   98.58±81.18	   -­‐	   t=-­‐5.63	   <0.001**	  
Pain	  Intensity	  §	   4.18±2.19	   4.28±1.89	   -­‐	   t=-­‐0.21	   0.834	  
FABQ-­‐w	  §	   13.63±13.28	   12.55±12.01	   -­‐	   t=0.36	   0.723	  
FABQ-­‐p	  §	   11.77±6.22	   13.81±5.08	   -­‐	   t=-­‐1.54	   0.127	  
ODI	  §	   19±14.97%	   29.88±18.79%	   -­‐	   t=-­‐2.47	   0.016*	  
BDI	  §	   8.45±7.88	   10.36±9.91	   -­‐	   t=-­‐0.82	   0.414	  
	  
Age	  is	  measured	  in	  years,	  pain	  duration	  is	  measured	  in	  months,	  pain	  intensity	  is	  
measured	  using	  a	  0-­‐10	  pain	  scale,	  FABQ-­‐w:	  Fear-­‐avoidance	  belief	  questionnaire	  –	  
work	  component,	  FABQ-­‐p:	  Fear-­‐avoidance	  belief	  questionnaire	  –	  physical	  
component,	  ODI:	  Oswestery	  disability	  index,	  BDI:	  Beck	  depression	  inventory.	  	  
†	  Chi-­‐square 
‡ One-­‐way	  ANOVA 
§ Independent	  2-­‐sample	  t-­‐test	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Table	  3.2:	  Non-­‐significant	  trends	  (puncorrected	  <	  0.001,	  100	  voxels)	  showing	  overall	  
gray	  matter	  volume	  differences.	  
Contrast	   Location	   Size	  
Healthy>cLBP	   Middle	  frontal	  gyrus	   603	  
	   Precuneus	   352	  
	   Fusiform	   264	  
	   Middle	  temporal	  gyrus	   234	  
	   Parahippocampal	  gyrus	   208	  
	   Postcentral	  gyrus	   205	  
	   Superior	  frontal	  gyrus	   196	  
	   Medial	  frontal	  gyrus	   181	  
	   Cerebellum	   123	  
	   Parahippocampal	  gyrus	   122	  
	   Lingual	  gyrus	   101	  
	   Superior	  frontal	  gyrus	   100	  
cLBP>Healthy	   Cerebellum	   342	  
	   Cerebellum	   195	  
Healthy>sLBP	   Middle	  temporal	  gyrus	   1506	  
	   Cingulate	  gyrus	   530	  
	   Inferior	  frontal	  gyrus	   351	  
	   Occipito-­‐temporal	  gyrus	   266	  
	   Caudate	   241	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   Superior	  frontal	  gyrus	   224	  
	   Inferior	  frontal	  gyrus	   182	  
	   Precuneus	   122	  
	   Middle	  frontal	  gyrus	   119	  
	   Parahippocampal	  gyrus	   110	  
	   Middle	  temporal	  gyrus	   106	  
sLBP>Healthy	   No	  differences	   -­‐	  
sLBP>cLBP	   Pons	   123	  
cLBP>sLBP	   Cingulate	  gyrus	   123	  
	  
cLBP:	  Chronic	  LBP,	  sLBP:	  Subacute	  low	  back	  pain.	  Size	  is	  in	  voxels.	  All	  the	  contrasts	  
indicate	  more	  gray	  matter	  in	  the	  first	  group	  as	  compared	  to	  the	  second	  group.	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Table	  3.3:	  Correlation	  of	  clinical	  outcome	  measures	  and	  normalized	  whole-­‐brain	  
volume.	  
Characteristic	   Statistic	   NWBV	   p	  
Pain	  Duration	   Partial	  correlation	   0.179	   0.109	  
Pain	  Intensity	   Partial	  correlation	   0.098	   0.382	  
FABQ-­‐w	   Partial	  correlation	   0.068	   0.546	  
FABQ-­‐p	   Partial	  correlation	   0.167	   0.136	  
ODI	   Partial	  correlation	   0.091	   0.418	  
BDI	   Partial	  correlation	   -­‐0.059	   0.600	  
	  
FABQ-­‐w:	  Fear-­‐avoidance	  belief	  questionnaire	  –	  work	  component,	  FABQ-­‐p:	  Fear-­‐
avoidance	  belief	  questionnaire	  –	  physical	  component,	  ODI:	  Oswestry	  disability	  
index,	  BDI:	  Beck	  depression	  inventory,	  NWBV:	  normalized	  whole-­‐bran	  volume.	  
All	  correlations	  are	  partial	  correlations	  after	  controlling	  for	  age,	  sex,	  and	  scanner.	  
The	  number	  of	  participants	  is	  84	  for	  all	  the	  outcome	  measures	  including	  
participants	  from	  both	  the	  subacute	  and	  chronic	  LBP	  groups.	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1.	  Overview:	  
Low	  back	  pain	  (LBP)	  is	  one	  of	  the	  most	  common	  chronic	  pain	  conditions	  
worldwide	  (Andersson,	  1999;	  Von	  Korff	  and	  Dunn,	  2008).	  Up	  till	  today	  almost	  85%	  
of	  LBP	  cases	  have	  a	  diagnosis	  of	  “nonspecific	  LBP”	  which	  indicates	  that	  there	  is	  no	  
actual	  known	  cause	  for	  the	  pain	  (Deyo	  and	  Weinstein,	  2001).	  Consequently	  those	  
cases	  end	  up	  being	  treated	  nonspecifically.	  This	  might	  be	  a	  reason	  for	  the	  common	  
progression	  of	  LBP	  from	  an	  acute/subacute	  phase	  into	  recurrent,	  and	  then	  chronic	  
LBP.	  Chronic	  LBP	  has	  major	  economic	  impacts	  on	  the	  society	  (Walker,	  Muller	  et	  al.,	  
2003;	  Katz,	  2006)	  and	  is	  usually	  accompanied	  by	  other	  psychosocial	  aspects	  that	  
make	  the	  case	  much	  more	  complicated	  and	  harder	  to	  treat	  (Ramond-­‐Roquin,	  Bouton	  
et	  al.,	  2015).	  As	  a	  common	  pain	  phenomenon,	  and	  since	  pain	  is	  processed	  in	  the	  
brain,	  brain	  imaging	  studies	  have	  immerged	  in	  attempt	  to	  understand	  how	  brain	  
regions	  are	  involved	  in	  LBP.	  All	  previous	  studies	  that	  have	  examined	  the	  brain	  and	  
studied	  its	  relationship	  to	  LBP	  have	  been	  conducted	  in	  the	  chronic	  population	  
(Apkarian,	  Sosa	  et	  al.,	  2004;	  Tagliazucchi,	  Balenzuela	  et	  al.,	  2010;	  Sharma,	  McCarson	  
et	  al.,	  2011).	  It	  is	  very	  critical	  to	  understand	  brain	  involvement	  earlier	  in	  the	  pain	  
stage	  to	  see	  if	  progression	  to	  chronic	  stage	  can	  be	  slowed	  down	  or	  even	  prevented.	  	  
	  
There	  is	  a	  huge	  gap	  in	  the	  literature	  regarding	  understanding	  of	  LBP	  and	  its	  
relation	  to	  the	  brain.	  Brain	  function	  has	  been	  examined	  by	  a	  number	  of	  researchers	  
in	  response	  to	  different	  stimuli	  and	  during	  rest	  in	  the	  chronic	  LBP	  population.	  The	  
general	  findings	  indicate	  an	  increased	  activation	  in	  the	  regions	  that	  are	  related	  to	  
pain	  processing	  (Giesecke,	  Gracely	  et	  al.,	  2004;	  Kobayashi,	  Kurata	  et	  al.,	  2009;	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Tagliazucchi,	  Balenzuela	  et	  al.,	  2010).	  A	  possible	  explanation	  for	  such	  findings	  was	  
that	  this	  increased	  activation	  might	  be	  a	  role	  player	  in	  relation	  to	  the	  chronicity	  of	  
pain	  in	  this	  population.	  From	  a	  neurochemical	  perspective,	  studies	  have	  shown	  that	  
people	  with	  chronic	  LBP	  have	  altered	  levels	  of	  neurochemicals	  in	  their	  brains	  
(Grachev,	  Fredrickson	  et	  al.,	  2000;	  Gussew,	  Rzanny	  et	  al.,	  2011;	  Sharma,	  McCarson	  
et	  al.,	  2011;	  Sharma,	  Brooks	  et	  al.,	  2012).	  Also,	  studies	  have	  reported,	  including	  
studies	  conducted	  in	  our	  lab,	  that	  altered	  levels	  of	  neurochemicals	  correlate	  with	  
the	  clinical	  presentation	  of	  LBP.	  Those	  findings	  indicate	  that	  the	  brain	  might	  be	  
functioning	  differently	  in	  people	  with	  LBP.	  Nonetheless,	  those	  findings	  are	  not	  
limited	  to	  chronic	  LBP.	  Alterations	  in	  brain	  function	  and	  neurochemistry	  have	  also	  
been	  reported	  in	  multiple	  pain	  conditions	  such	  as	  fibromyalgia	  (Cagnie	  et	  al.,	  2014),	  
complex	  regional	  pain	  syndrome	  (Schwenkreis	  et	  al.,	  2009),	  and	  migraine	  (Schwedt	  
and	  Chong,	  2015).	  
	  
Examining	  brain	  volume	  is	  another	  way	  to	  study	  the	  relationship	  between	  
the	  brain	  and	  any	  medical	  condition.	  This	  method	  has	  been	  explored	  in	  several	  
conditions	  such	  as	  Alzheimer’s	  disease	  (Karas,	  Scheltens	  et	  al.,	  2004;	  Ibrahim,	  
Horacek	  et	  al.,	  2009;	  Gordon,	  Blazey	  et	  al.,	  2013),	  schizophrenia	  (Cahn,	  Hulshoff	  Pol	  
et	  al.,	  2002;	  Kasparek,	  Prikryl	  et	  al.,	  2009),	  and	  multiple	  sclerosis	  (Cheriyan,	  Kim	  et	  
al.,	  2012;	  Koenig,	  Sakaie	  et	  al.,	  2014;	  Radue,	  Barkhof	  et	  al.,	  2015).	  It	  has	  also	  been	  
studied	  in	  a	  number	  of	  pain	  conditions	  including	  fibromyalgia	  (Kuchinad,	  
Schweinhardt	  et	  al.,	  2007;	  Diaz-­‐Piedra,	  Guzman	  et	  al.,	  2015;	  McCrae,	  O'Shea	  et	  al.,	  
2015),	  complex	  regional	  pain	  syndrome	  (Geha,	  Baliki	  et	  al.,	  2008;	  Barad,	  Ueno	  et	  al.,	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2014),	  and	  chronic	  LBP	  (Apkarian,	  Sosa	  et	  al.,	  2004;	  Ivo,	  Nicklas	  et	  al.,	  2013;	  
Dolman,	  Loggia	  et	  al.,	  2014).	  Within	  the	  LBP	  arena	  only	  7	  studies	  have	  examined	  
brain	  volume.	  Their	  results	  were	  inconsistent.	  Three	  studies	  reported	  volumetric	  
differences	  while	  the	  other	  four	  reported	  no	  differences	  when	  comparing	  brain	  
volume	  between	  participants	  with	  chronic	  LBP	  and	  healthy	  controls.	  Such	  
inconsistencies	  indicate	  the	  lack	  of	  our	  knowledge	  in	  this	  field,	  and	  this	  is	  why	  we	  
decided	  to	  create	  the	  current	  study	  with	  the	  largest	  sample	  size	  and	  the	  strictest	  
methods	  to	  determine	  whether	  or	  not	  there	  is	  a	  relationship	  between	  LBP	  (subacute	  
and	  chronic)	  and	  brain	  volume.	  
	  
Brain	  volume	  can	  be	  measured	  overall	  using	  volumetric	  measurements,	  or	  it	  
can	  be	  measured	  in	  a	  cluster-­‐based	  method,	  which	  is	  voxel-­‐based	  morphometry	  
(VBM).	  Volumetric	  measurements	  indicate	  the	  overall	  differences	  in	  brain	  volume	  
(gray	  matter,	  white	  matter,	  and	  cerebro-­‐spinal	  fluid)	  but	  without	  indicating	  the	  
location	  of	  any	  potential	  differences.	  It	  is	  of	  paramount	  importance	  to	  understand	  
the	  importance	  of	  “location”	  when	  examining	  brain	  volume	  differences.	  Therefore,	  
VBM	  is	  a	  tool	  that	  is	  used	  to	  create	  brain	  probability	  maps	  that	  show	  where	  
potential	  differences	  of	  brain	  volume	  exist	  when	  comparing	  different	  groups	  of	  
participants.	  We	  used	  both	  methods	  in	  our	  study.	  However,	  given	  that	  pain	  is	  a	  
complex	  phenomenon	  and	  is	  composed	  of	  two	  main	  components	  (sensory	  and	  
affective	  pain)	  we	  also	  wanted	  to	  examine	  the	  specific	  regions	  in	  the	  brain	  that	  
process	  the	  different	  components	  of	  pain.	  Therefore,	  we	  created	  brain	  masks	  for	  all	  
the	  pain	  processing	  regions	  and	  we	  extracted	  the	  brain	  volumes	  from	  those	  regions	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and	  compared	  them	  across	  our	  groups.	  It	  is	  important	  to	  mention	  that	  while	  
running	  all	  of	  our	  analyses,	  we	  included	  age,	  sex,	  and	  scanner	  differences	  (since	  we	  
had	  data	  collected	  on	  2	  scanners)	  as	  covariates.	  Age	  and	  sex	  are	  major	  contributors	  
to	  differences	  in	  brain	  volume	  (Gur	  et	  al.,	  2002;	  Cowell	  et	  al.,	  2007;	  Nordenskjold	  et	  
al.,	  2013).	  Also,	  different	  scanner	  types	  may	  cause	  some	  differences	  in	  results;	  
however,	  we	  used	  the	  exact	  same	  image	  acquisition	  parameters	  from	  both	  scanners	  
(for	  image	  parameters	  please	  refer	  to	  Chapter	  III).	  Yet,	  we	  included	  all	  3	  factors	  as	  
covariates	  in	  our	  analyses	  in	  an	  attempt	  to	  control	  for	  as	  many	  variables	  as	  we	  can	  
and	  to	  make	  our	  results	  as	  close	  to	  what	  LBP	  would	  truly	  affect	  the	  brain.	  
	  
We	  have	  been	  conducting	  brain	  imaging	  studies	  in	  our	  lab	  for	  the	  past	  6	  
years,	  mainly	  examining	  the	  LBP	  population	  (both	  subacute	  and	  chronic	  LBP).	  I	  have	  
utilized	  the	  data	  collected	  previously	  and	  added	  a	  prospective	  study	  that	  allowed	  us	  
to	  continue	  to	  collect	  data	  about	  the	  subacute	  LBP	  participants.	  The	  total	  number	  of	  
participants	  included	  in	  this	  study	  was	  130,	  23	  with	  subacute	  LBP,	  68	  with	  chronic	  
LBP,	  and	  39	  healthy	  controls.	  We	  acquired	  structural	  brain	  scans	  from	  all	  
participants,	  and	  collected	  clinical	  outcome	  measures	  from	  both	  LBP	  groups	  (those	  
measures	  included	  pain	  duration,	  pain	  intensity,	  fear	  avoidance,	  disability,	  and	  
depression	  symptoms).	  We	  then	  extracted	  the	  data	  from	  the	  preprocessed	  brain	  
images	  and	  calculated	  the	  normalized	  whole-­‐brain	  volumes	  (aim	  1).	  Afterwards,	  
using	  the	  VBM8	  toolbox,	  we	  conducted	  statistical	  testing	  on	  a	  voxel-­‐by-­‐voxel	  level	  to	  
examine	  volumetric	  differences	  between	  groups	  on	  a	  whole-­‐brain	  level	  (aim	  1)	  and	  
in	  specific	  ROIs	  (aim	  2)	  that	  were	  related	  to	  pain	  processing.	  Finally,	  we	  ran	  partial	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correlation	  analyses	  between	  the	  clinical	  outcome	  measures	  and	  the	  normalized	  
whole-­‐brain	  volumes	  in	  order	  to	  determine	  whether	  there	  is	  a	  relationship	  between	  
those	  measures	  and	  brain	  volume	  (aim	  3).	  Again,	  for	  all	  the	  previous	  analyses	  we	  
included	  age,	  sex,	  and	  scanner	  as	  covariates.	  	  
	  
2.	  Summary	  of	  Findings:	  
Aim	  1:	  To	  determine	  whether	  subjects	  with	  subacute	  and	  chronic	  LBP	  have	  
altered	  whole-­‐brain	  volume	  compared	  to	  healthy	  controls.	  	  
	  
Hypothesis	  1a:	  Volumetric	  measurements	  of	  normalized	  whole-­‐brain	  volume	  will	  show	  
less	  volume	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  as	  compared	  to	  healthy	  controls,	  
and	  less	  volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
Hypothesis	  1b:Voxel-­‐wise	  whole-­‐brain	  volume	  determined	  by	  VBM	  will	  show	  less	  GM	  
volume	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  as	  compared	  to	  healthy	  controls,	  and	  
less	  volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypothesis	  1a:	  After	  running	  an	  overall	  ANOVA	  comparing	  normalized	  whole-­‐brain	  
volumes	  between	  our	  groups	  no	  significant	  differences	  were	  noticed	  
(F(2,124)=1.63,	  p=0.20,	  η2=0.03).	  This	  indicates	  that	  we	  could	  not	  detect	  a	  
significant	  difference	  in	  normalized	  whole-­‐brain	  volumes	  between	  the	  3	  groups.	  We	  
conclude	  that	  there	  is	  a	  minimum	  to	  no-­‐effect	  of	  LBP	  on	  normalized	  whole-­‐brain	  
volume	  regardless	  of	  its	  duration.	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Hypothesis	  1b:	  After	  running	  whole-­‐brain	  voxel-­‐wise	  comparison	  we	  also	  did	  not	  
notice	  any	  differences	  in	  brain	  volume	  between	  groups	  after	  correcting	  for	  multiple	  
comparisons	  (all	  p	  >	  0.05).	  Again	  this	  indicates	  that	  we	  could	  not	  detect	  a	  significant	  
effect	  of	  LBP	  on	  brain	  volume	  while	  using	  VBM	  as	  a	  measurement	  method.	  For	  both	  
those	  tests	  we	  used	  age,	  sex,	  and	  scanner	  as	  covariates.	  
	  
Aim	  2:	  To	  determine	  whether	  subjects	  with	  subacute	  and	  chronic	  LBP	  have	  
altered	  regional	  brain	  volume	  compared	  to	  healthy	  controls.	  
	  
Hypothesis	  2a:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  sensory	  
regions	  (primary	  somatosensory	  cortex	  and	  posterior	  insula)	  in	  the	  subacute	  and	  
chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  the	  chronic	  
group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
Hypothesis	  2b:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  cortical	  
affective	  regions	  (cingulate,	  orbitofrontal,	  and	  medial	  prefrontal	  cortices,	  and	  anterior	  
insula)	  in	  the	  subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  
volume	  in	  the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
Hypothesis	  2c:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  subcortical	  
affective	  regions	  (nucleus	  accumbens,	  amygdala,	  caudate,	  and	  hippocampus)	  in	  the	  
subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  the	  
chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	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Hypothesis	  2d:	  Regional	  VBM	  analysis	  will	  show	  less	  GM	  volume	  within	  the	  thalamus	  in	  
the	  subacute	  and	  chronic	  LBP	  groups	  compared	  to	  healthy	  controls,	  and	  less	  volume	  in	  
the	  chronic	  group	  as	  compared	  to	  the	  subacute	  LBP	  group.	  
	  
Hypotheses	  2a,	  c,	  and	  d:	  After	  creating	  masks	  for	  specific	  pain	  processing	  regions	  and	  
examining	  regional	  brain	  volumes	  we	  were	  not	  able	  to	  detect	  any	  significant	  
differences	  (after	  correcting	  for	  multiple	  comparisons)	  in	  brain	  volume	  between	  our	  
groups	  (all	  p	  >	  0.05).	  This	  indicates	  that	  LBP	  has	  minimum	  to	  no	  effect	  on	  brain	  
volume	  in	  pain	  processing	  regions	  within	  the	  brain	  regardless	  of	  its	  duration.	  	  
	  
Hypothesis	  2b:	  While	  examining	  the	  cortical	  affective	  mask	  (somatosensory	  cortex	  
and	  posterior	  insula)	  we	  were	  able	  to	  detect	  2	  voxels	  (6.75	  mm3)	  that	  showed	  less	  
GM	  volume	  in	  the	  chronic	  LBP	  group	  as	  compared	  to	  healthy	  controls.	  This	  indicates	  
a	  minimum	  effect	  of	  chronic	  LBP	  on	  brain	  volume	  in	  the	  somatosensory	  cortex.	  No	  
differences	  were	  noticed	  regarding	  the	  subacute	  group.	  	  
	  
It	  is	  worth	  mentioning	  here	  that	  this	  method	  of	  examining	  the	  different	  pain	  related	  
regions	  and	  creating	  affective	  and	  sensory	  masks	  is	  a	  new	  method	  that	  has	  not	  been	  
employed	  by	  any	  of	  the	  previous	  studies	  examining	  the	  LBP	  population.	  It	  allowed	  
us	  to	  gain	  a	  focused	  view	  on	  those	  pain	  processing	  regions,	  and	  yet	  we	  only	  noticed	  
differences	  in	  2	  voxels	  in	  one	  of	  those	  masks	  indicating	  how	  minimal	  the	  effect	  of	  
LBP	  is	  on	  brain	  structure.	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Aim	  3:	  To	  determine	  the	  relationship	  between	  clinical	  outcome	  measures	  and	  
normalized	  whole-­‐brain	  volume	  within	  both	  LBP	  groups.	  
	  
Hypothesis	  3a:	  Pain	  duration	  (measured	  in	  months)	  will	  be	  negatively	  correlated	  with	  
normalized	  whole-­‐brain	  volume.	  
Hypothesis	  3b:	  Pain	  intensity	  (measured	  with	  0-­‐10	  pain	  scale)	  will	  be	  negatively	  
correlated	  with	  normalized	  whole-­‐brain	  volume.	  
Hypothesis	  3c:	  Fear	  avoidance	  (measured	  by	  the	  Fear	  Avoidance	  Belief	  Questionnaire)	  
will	  be	  negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	  
Hypothesis	  3d:	  Disability	  scores	  (measured	  by	  the	  Oswestry	  Disability	  Index)	  will	  be	  
negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	  
Hypothesis	  3e:	  Depressive	  symptoms	  (measured	  by	  Beck’s	  Depression	  Inventory-­‐II)	  will	  
be	  negatively	  correlated	  with	  normalized	  whole-­‐brain	  volume.	  
	  
Hypotheses	  3a,	  b,	  c,	  d,	  and	  e:	  After	  running	  the	  partial	  correlations	  between	  clinical	  
outcome	  measures	  and	  normalized	  whole-­‐brain	  volumes	  we	  were	  not	  able	  to	  detect	  
any	  significant	  correlation	  (negative	  or	  positive).	  This	  indicates	  the	  clinical	  
presentation	  of	  LBP	  (subacute	  or	  chronic)	  including	  pain	  duration,	  pain	  intensity,	  
fear	  of	  movement,	  disability,	  and	  depressive	  symptoms	  are	  not	  correlated	  with	  
normalized	  whole-­‐brain	  volume.	  All	  those	  partial	  correlations	  included	  age,	  sex,	  and	  
scanner	  as	  covariates.	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3.	  Clinical	  Implications:	  
Clinical	  implications	  from	  brain	  imaging	  studies	  can	  be	  challenging.	  This	  is	  
mainly	  due	  to	  the	  fact	  that	  we	  have	  limited	  understanding	  of	  the	  real	  meanings	  of	  
“volumetric	  brain	  differences”.	  Yet,	  our	  findings	  indicate	  that	  there	  is	  minimum	  to	  
no	  effect	  of	  LBP	  on	  brain	  volume.	  To	  gain	  a	  better	  understanding	  of	  clinically	  
meaningful	  differences	  of	  volumetric	  changes,	  we	  calculated	  the	  effect	  size	  from	  our	  
study	  and	  the	  previous	  studies.	  We	  found	  that	  the	  effect	  size	  of	  LBP	  within	  our	  study	  
was	  0.07,	  which	  is	  a	  very	  small	  effect	  size.	  At	  this	  effect	  size,	  and	  in	  order	  to	  see	  a	  
true	  effect	  of	  LBP	  on	  brain	  structure	  we	  will	  need	  a	  total	  of	  1722	  participants.	  None	  
of	  the	  previous	  studies,	  including	  our	  own,	  were	  remotely	  close	  to	  this	  sample	  size.	  
This	  is	  in	  agreement	  with	  the	  conclusion	  of	  the	  most	  recently	  published	  paper	  in	  this	  
field.	  Dolman	  et	  al.	  (2014)	  indicated	  that	  most	  of	  the	  previously	  published	  results	  
indicating	  volumetric	  differences	  in	  people	  with	  LBP	  might	  have	  been	  
overestimated.	  They	  suggested	  that	  controlling	  for	  the	  main	  covariates	  that	  may	  
affect	  brain	  volume	  (as	  age,	  sex,	  and	  pain	  descriptors)	  might	  diminish	  or	  even	  
eliminate	  the	  volumetric	  differences,	  which	  would	  indicate	  that	  such	  differences	  are	  
not	  related	  to	  LBP	  directly.	  On	  the	  other	  hand,	  we	  were	  able	  to	  detect	  some	  minor	  
differences	  within	  the	  affective	  cortical	  brain	  mask	  in	  2	  voxels	  after	  controlling	  for	  
covariates	  and	  correcting	  for	  multiple	  comparisons.	  This	  finding	  is	  statistically	  
significant;	  however,	  clinically	  it	  is	  not.	  A	  difference	  of	  2	  voxels	  (6.75	  mm3)	  at	  best	  
might	  be	  described	  as	  a	  pattern,	  especially	  that	  the	  threshold	  for	  cluster-­‐based	  
analysis	  is	  usually	  higher	  than	  that	  within	  VBM.	  Therefore,	  if	  there	  was	  an	  effect	  of	  
LBP	  on	  brain	  volume	  it	  is	  very	  minimal,	  according	  to	  our	  results.	  Studies	  have	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demonstrated	  that	  there	  is	  a	  5%	  decrease	  of	  brain	  volume	  per	  decade	  due	  to	  normal	  
aging	  (Resnick,	  Pham	  et	  al.,	  2003).	  According	  to	  our	  healthy	  controls,	  this	  
diminishment	  is	  equal	  to	  4-­‐6	  mm3	  a	  year.	  The	  6.75	  mm3	  that	  we	  have	  noticed	  in	  our	  
chronic	  LBP	  group	  was	  due	  to	  an	  average	  of	  9	  years	  of	  pain,	  which	  means	  that	  it	  has	  
an	  effect	  of	  <1	  mm3	  on	  average	  every	  year.	  Therefore	  it	  can	  be	  seen	  that	  the	  effect	  of	  
normal	  aging	  is	  much	  bigger	  than	  the	  effect	  of	  chronic	  LBP	  in	  our	  cohort,	  indicating	  
that	  this	  decrease	  is	  not	  clinically	  significant.	  
	  
The	  common	  explanation	  from	  previous	  studies	  that	  have	  noticed	  volumetric	  
differences	  was	  related	  to	  glutamate	  neurotoxicity.	  Glutamate	  levels	  are	  increased	  
in	  pain	  related	  regions	  in	  the	  brain	  when	  experiencing	  pain	  (Mullins,	  Rowland	  et	  al.,	  
2005),	  and	  increased	  levels	  of	  glutamate	  can	  be	  neurotoxic	  and	  cause	  neuronal	  
degeneration	  (Rothstein,	  1996).	  Nonetheless,	  neuronal	  degeneration	  can	  also	  be	  
accompanied	  by	  tissue	  scarring	  and	  cortical	  thickening	  (Buffo,	  Rite	  et	  al.,	  2008;	  
Dolman,	  Loggia	  et	  al.,	  2014).	  It	  is	  possible	  that	  glutamate	  is	  causing	  neuronal	  
degeneration,	  but	  also	  leading	  to	  cell	  hypertrophy.	  Current	  brain	  imaging	  
technology	  is	  not	  sophisticated	  enough	  to	  pick	  up	  a	  single	  neuron	  and	  examine	  it’s	  
volume,	  therefore	  from	  a	  brain	  imaging	  perspective	  we	  cannot	  examine	  single	  cell	  
volume.	  Such	  questions	  can	  be	  answered	  with	  histology	  studies.	  Therefore,	  there	  is	  
a	  possibility	  that	  neuronal	  degeneration	  is	  taking	  place	  in	  the	  brain,	  yet	  using	  
structural	  brain	  imaging	  we	  cannot	  truly	  detect	  it.	  This	  might	  be	  an	  explanation	  of	  
why	  functional	  and	  neurochemical	  studies	  have	  much	  less	  inconsistencies	  when	  it	  
comes	  to	  examining	  participants	  with	  LBP	  compared	  to	  healthy	  controls.	  It	  also	  may	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explain	  the	  two	  studies	  that	  have	  noticed	  increased	  brain	  volumes	  in	  pain	  
processing	  regions	  in	  participants	  with	  chronic	  LBP	  when	  compared	  to	  healthy	  
controls	  (Schmidt-­‐Wilcke,	  Leinisch	  et	  al.,	  2006;	  Dolman,	  Loggia	  et	  al.,	  2014).	  
	  
Our	  findings,	  exemplified	  by	  not	  being	  able	  to	  detect	  volumetric	  differences	  
in	  participants	  with	  LBP,	  deliver	  good	  news	  to	  those	  patients.	  Previous	  studies	  
indicated	  that	  LBP	  has	  a	  significant	  impact	  on	  brain	  volume	  and	  such	  findings	  can	  be	  
very	  alarming	  and	  frightening	  to	  patients.	  However,	  we	  noticed	  after	  conducting	  this	  
study	  with	  a	  large	  sample	  size	  and	  the	  most	  stringent	  methodology,	  that	  those	  
previous	  findings	  may	  have	  been	  overestimated.	  LBP	  might	  have	  an	  effect	  on	  brain	  
function	  and	  neurochemistry;	  nonetheless	  we	  were	  not	  able	  to	  detect	  any	  
volumetric	  differences	  related	  to	  it.	  LBP	  and	  the	  accompanying	  psychosocial	  aspects	  
can	  be	  very	  limiting	  to	  patients,	  and	  letting	  patients	  understand	  that	  their	  pain	  is	  not	  
affecting	  their	  brain	  structure	  can	  be	  a	  great	  relief.	  Potentially,	  it	  can	  help	  patients	  
overcome	  their	  fears	  and	  gain	  hope	  for	  getting	  better.	  	  
	  
Clinicians	  can	  use	  those	  findings	  and	  explain	  to	  their	  patients	  that	  there	  
might	  be	  some	  changes	  in	  their	  brain	  function	  or	  neurochemistry	  related	  to	  their	  
pain;	  however,	  it	  is	  not	  represented	  in	  brain	  volume.	  Many	  practices	  can	  be	  used	  in	  
order	  to	  encourage	  patients	  to	  get	  better,	  such	  as	  exercise	  and	  physical	  therapy.	  
With	  this	  knowledge	  in	  mind	  patients	  might	  feel	  encouraged	  to	  adhere	  to	  practices	  
recommended	  by	  clinicians	  and	  therefore	  help	  improve	  their	  condition.	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4.	  Limitations:	  
As	  with	  any	  other	  study,	  we	  acknowledge	  that	  we	  have	  a	  number	  of	  
limitations	  to	  our	  current	  study,	  and	  those	  limitations	  are:	  
	  
1. Retrospective	  analysis:	  	  
Most	  of	  the	  data	  used	  in	  this	  study	  has	  been	  collected	  previously	  for	  studies	  
conducted	  in	  our	  lab,	  yet	  we	  added	  a	  prospective	  arm	  to	  recruit	  more	  participants	  
with	  subacute	  LBP.	  This	  indicates	  that	  the	  inclusion/exclusion	  criteria	  were	  made	  
for	  other	  studies	  rather	  than	  specifically	  for	  this	  current	  one	  which	  could	  potentially	  
be	  a	  limitation.	  
	  
2. Significant	  age	  difference	  between	  groups:	  
Participants	  who	  were	  in	  the	  chronic	  LBP	  group	  were	  significantly	  older	  than	  those	  
in	  the	  subacute	  group.	  This	  finding	  was	  expected	  since	  the	  way	  those	  groups	  were	  
designed	  was	  based	  on	  the	  duration	  of	  their	  pain,	  thus	  participants	  with	  chronic	  LBP	  
were	  older	  than	  those	  with	  subacute	  LBP.	  Yet	  we	  included	  age	  as	  a	  covariate	  in	  all	  
our	  analyses.	  
	  
3. Significant	  sex	  difference	  between	  groups:	  
Again,	  the	  chronic	  group	  had	  more	  female	  participants	  in	  it	  than	  males,	  which	  was	  
also	  expected.	  Chronic	  pain	  is	  more	  common	  in	  females	  than	  in	  males	  (Mogil,	  2012)	  
and	  that	  was	  represented	  in	  our	  sample.	  We	  included	  sex	  as	  a	  covariate	  in	  all	  our	  
analyses.	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4. Using	  two	  scanners:	  
All	  data	  were	  collected	  at	  the	  Hoglund	  Brain	  Imaging	  Center	  over	  the	  past	  6	  years.	  
Through	  those	  6	  years	  the	  brain	  imaging	  center	  has	  replaced	  its	  old	  Allegra	  scanner	  
with	  a	  Skyra	  scanner.	  Our	  results	  were	  a	  compilation	  of	  data	  collected	  on	  both	  
scanners.	  This	  might	  have	  affected	  our	  results,	  yet	  all	  the	  imaging	  parameters	  were	  
exactly	  the	  same.	  In	  addition	  we	  added	  scanner	  as	  a	  covariate	  in	  all	  our	  analyses.	  
	  
5. Inclusion/exclusion	  criteria:	  
We	  have	  excluded	  participants	  with	  higher	  levels	  of	  pain	  (more	  than	  8	  on	  a	  0-­‐10	  
pain	  scale)	  because	  this	  was	  the	  criteria	  for	  the	  previous	  studies	  since	  they	  had	  an	  
exercise	  component	  to	  them.	  This	  indicates	  that	  we	  were	  not	  able	  to	  include	  
subjects	  with	  extreme	  amounts	  of	  pain.	  Such	  a	  subset	  of	  the	  population	  would	  be	  
interesting	  to	  examine,	  yet	  recruiting	  them	  would	  be	  hard	  and	  asking	  them	  to	  lay	  in	  
the	  scanner	  flat	  on	  their	  backs	  will	  be	  very	  challenging.	  We	  also	  excluded	  
participants	  with	  any	  hip,	  knee,	  or	  ankle	  joint	  conditions.	  LBP	  is	  common	  in	  people	  
who	  have	  pain	  in	  other	  joints;	  yet	  again	  this	  was	  part	  of	  the	  exclusion	  criteria	  for	  the	  
previous	  studies.	  
	  
5.	  Future	  Directions:	  
There	  are	  many	  future	  directions	  for	  this	  line	  of	  research,	  especially	  since	  
brain	  imaging	  in	  people	  with	  LBP	  is	  a	  relatively	  new	  and	  emerging	  field.	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1. Longitudinal	  study	  design:	  
Longitudinal	  studies	  are	  necessary	  to	  address	  the	  question	  of	  “the	  chicken	  or	  the	  
egg”.	  Given	  that	  our	  findings	  did	  not	  indicate	  any	  potential	  structural	  brain	  
differences	  in	  people	  with	  LBP	  from	  a	  cross-­‐sectional	  aspect,	  it	  would	  be	  interesting	  
to	  examine	  brain	  differences	  before	  and	  after	  being	  affected	  by	  LBP.	  Certain	  
populations	  are	  more	  prone	  to	  developing	  LBP	  than	  others	  (such	  as	  labor	  workers).	  
Those	  populations	  can	  be	  targeted,	  scanned,	  and	  followed-­‐up	  on	  in	  an	  attempt	  to	  get	  
a	  longitudinal	  view	  on	  LBP.	  This	  would	  be	  a	  better	  study	  design	  and	  would	  grant	  us	  
a	  better	  understanding	  of	  the	  true	  effects	  of	  LBP	  on	  brain	  structure.	  Such	  studies	  are	  
very	  expensive,	  time	  consuming,	  and	  really	  hard	  to	  conduct	  (with	  the	  follow	  up	  
scans);	  however,	  they	  are	  definitely	  needed.	  	  
	  
2. Different	  inclusion/exclusion	  criteria:	  
Another	  option	  for	  a	  future	  study	  design	  would	  include	  classifying	  participants	  
based	  on	  their	  pain	  duration,	  intensity,	  or	  type	  of	  pain	  (for	  example,	  neuropathic	  vs.	  
non-­‐neuropathic	  pain).	  We	  could	  not	  detect	  brain	  volumetric	  differences	  in	  a	  
general	  population	  of	  LBP	  participants;	  however,	  maybe	  the	  effect	  of	  pain	  can	  be	  
magnified	  in	  people	  with	  higher	  vs.	  lower	  intensities	  of	  pain,	  or	  longer	  duration	  vs,	  
shorter	  duration	  of	  pain.	  We	  did	  not	  see	  any	  correlation	  with	  pain	  duration	  or	  pain	  
intensity,	  but	  that	  still	  does	  not	  necessarily	  indicate	  that	  they	  cannot	  be	  split	  based	  
on	  those	  clinical	  measures.	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3. Using	  other	  brain	  imaging	  modalities:	  
We	  examined	  brain	  volume	  using	  structural	  brain	  imaging;	  however,	  other	  studies	  
(including	  studies	  conducted	  in	  our	  lab)	  have	  used	  functional	  and	  spectroscopy	  
imaging	  methods	  in	  people	  with	  LBP.	  A	  future	  study	  may	  use	  a	  large	  sample	  size	  
(similar	  to	  the	  one	  in	  this	  current	  study)	  and	  examine	  the	  differences	  in	  brain	  
function	  and	  neurochemistry	  between	  people	  with	  LBP	  and	  healthy	  controls.	  
Resting	  state	  analysis	  can	  be	  a	  very	  interesting	  topic	  to	  explore	  in	  this	  population	  as	  
well	  (research	  on	  it	  being	  conducted	  currently	  in	  our	  lab).	  Another	  proposed	  study	  
design	  is	  looking	  at	  white	  matter	  volume	  in	  the	  brain,	  potentially	  using	  diffusion	  
tensor	  imaging.	  By	  using	  this	  methodology	  researchers	  can	  examine	  the	  white	  
matter	  tracts	  and	  try	  to	  examine	  any	  volumetric	  differences	  between	  participants	  
with	  LBP	  and	  healthy	  controls.	  
	  
4. No	  more	  VBM	  studies:	  
One	  of	  the	  future	  directions	  would	  be	  not	  to	  conduct	  more	  VBM	  studies,	  specifically	  
in	  LBP	  population	  without	  involvement	  of	  other	  secondary	  effects	  i.e.	  high	  
psychological	  involvement	  or	  depression.	  The	  results	  of	  our	  study	  indicate	  that	  the	  
effects	  of	  LBP	  on	  brain	  volume	  are	  minimal,	  if	  not	  nonexistent.	  Therefore	  we	  do	  not	  
recommend	  conducting	  any	  further	  studies	  that	  would	  use	  the	  same	  methodology	  to	  
answer	  the	  same	  question.	  This	  finding	  is	  essential	  because	  it	  will	  save	  researchers’	  
time,	  effort,	  and	  resources	  to	  investigate	  different	  topics.	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6.	  Conclusions:	  
In	  conclusion	  we	  believe	  that	  LBP,	  regardless	  of	  its	  duration,	  has	  a	  minimum	  
to	  no	  effect	  on	  brain	  volume.	  Also,	  given	  the	  findings	  from	  previous	  structural	  brain	  
imaging	  studies	  in	  LBP	  that	  indicated	  decreased	  brain	  volume	  in	  LBP	  participants,	  
we	  believe	  that	  those	  findings	  were	  overestimated.	  Multiple	  limitations	  may	  have	  
led	  to	  those	  conclusions	  from	  the	  previous	  studies	  including	  sample	  size,	  
methodology	  issues,	  or	  subject	  inclusion/exclusion	  criteria.	  Nonetheless,	  studies	  
examining	  brain	  function	  and	  neurochemistry	  (including	  studies	  conducted	  in	  our	  
lab)	  have	  found	  differences	  between	  participants	  with	  chronic	  LBP	  and	  healthy	  
controls.	  This	  might	  indicate	  that	  LBP	  may	  affect	  brain	  function	  and	  
neurochemistry;	  however,	  not	  brain	  volume	  and	  structure.	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Appendices:	  
Appendix	  1:	  Fear	  Avoidance	  Belief	  Questionnaire.	  
	  
FEAR AVOIDANCE BELIEFS QUESTIONNAIRE (FABQ) 
 
Purpose: The FABQ was developed by Waddell to investigate fear-avoidance 
beliefs among LBP patients in the clinical setting.3  This survey can help predict 
those that have a high pain avoidance behavior.  Clinically, these people may 
need to be supervised more than those that confront their pain. 
 
Scoring:  The FABQ consists of 2 subscales, which are reflected in the division 
of the outcome form into 2 separate sections. The first subscale (items 1-5) is the 
Physical Activity subscale (FABQPA), and the second subscale (items 6-16) is 
the Work subscale (FABQW). Interestingly, not all items contribute to the score 
for each subscale; however the patient should still complete all items as these 
items were included when the reliability and validity of the scale was initially 
established. A low FABQW score (less than 19) was one of 5 variables in a 
clinical prediction rule that increased the probability of success from SI region 
manipulation in individuals with low back pain.1 Each subscale is graded 
separately by summing the responses respective scale items (0 – 6 for each 
item); for scoring purposes, only 4 of the physical activity scale items are scored 
(24 possible points) and only 7 of the work items (42 possible points).  The 
method to score each subscale is outlined below. (Note: It is extremely important 
to ensure all items are completed, as there is no procedure to adjust for 
incomplete items.) 
 
Scoring the Physical Activity subscale (FABQPA) 
Sum items 2, 3, 4, and 5 (the score circled by the patient for these items). 
 
Scoring the Work subscale (FABQW) 
Sum items 6, 7, 9, 10, 11, 12, and 15.  
 
Measurement Characteristics: The FABQ has been demonstrated to be valid 
and reliable in a chronic LBP population3 and appears to be a useful screening 
tool for identifying acute LBP patients who will not return to work by 4wks.2 
 
References: 
1. Flynn T, Fritz J, Whitman J, Wainner R, et al. Clinical Prediction Rule for 
Classifying Patients with Low Back Pain Likely to Respond to a Manipulation 
Technique. Spine (In Press) 2002. 
2. Fritz JM, George SZ, Delitto A. The role of fear-avoidance beliefs in acute low 
back pain: relationships with current and future disability and work status. Pain 
2001; 94:7-15. 
3. Waddell G, Newton M, Henderson I, Somerville D, Main CJ. A Fear-Avoidance 
Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic 
low back pain and disability. Pain 1993; 52:157-168 
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Name: ____________________________________________   Date: _____________________ 
 
Here are some of the things which other patients have told us about their pain.  For each statement please circle any 
number from 0 to 6 to say how much physical activities such as bending, lifting, walking or driving affect or would 
affect your back pain. 
 
       COMPLETELY                      UNSURE    COMPLETELY 
          DISAGREE              AGREE 
 
1.  My pain was caused by physical activity  0 1 2 3 4 5 6 
 
2.  Physical activity makes my pain worse  0 1 2 3 4 5 6 
 
3.  Physical activity might harm my back  0 1 2 3 4 5 6 
 
4.  I should not do physical activities  0 1 2 3 4 5 6 
     which (might) make my pain worse 
 
5.  I cannot do physical activities which  0 1 2 3 4 5 6 
     (might) make my pain worse 
 
 
The following statements are about how your normal work affects or would affect your back pain. 
 
       COMPLETELY                      UNSURE    COMPLETELY 
          DISAGREE              AGREE 
 
6.  My pain was caused by my work or by  0 1 2 3 4 5 6 
     an accident at work 
 
7.  My work aggravated my pain   0 1 2 3 4 5 6 
 
8.  I have a claim for compensation for my pain 0 1 2 3 4 5 6 
 
9.  My work is too heavy for me   0 1 2 3 4 5 6 
 
10.  My work makes or would make my pain worse 0 1 2 3 4 5 6 
 
11. My work might harm my back   0 1 2 3 4 5 6 
 
12.  I should not do my normal work with my 0 1 2 3 4 5 6  
      present pain 
 
13.  I cannot do my normal work with my   0 1 2 3 4 5 6 
       present pain 
 
14.  I cannot do my normal work until my pain  0 1 2 3 4 5 6 
       is treated 
 
15.  I do not think that I will be back to my  0 1 2 3 4 5 6 
       normal work within 3 months 
 
16.  I do not think that I will ever be able to go  0 1 2 3 4 5 6 
       back to that work 
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Appendix	  2:	  Beck	  Depression	  Inventory-­‐II.	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Appendix	  3:	  Oswestery	  Disability	  Index.	  
	  
Oswestry Low Back Disability Questionnaire  
 
 Page 2  
Oswestry Low Back Pain Disability Questionnaire 
Instructions 
This questionnaire has been designed to give us information as to how your back or leg pain is affecting  
your ability to manage in everyday life. Please answer by checking ONE box in each section for the 
statement which best applies to you. We realise you may consider that two or more statements in any one 
section apply but please just shade out the spot that indicates the statement which most clearly describes 
your problem. 
Section 1 – Pain intensity 
 I have no pain at the moment 
 The pain is very mild at the moment 
 The pain is moderate at the moment 
 The pain is fairly severe at the moment 
 The pain is very severe at the moment 
 The pain is the worst imaginable at the 
 moment 
 
Section 2 – Personal care (washing, dressing etc) 
 I can look after myself normally without  
 causing extra pain 
 I can look after myself normally but it  
 causes extra pain 
 It is painful to look after myself and I am  
 slow and careful 
 I need some help but manage most of my  
 personal care 
 I need help every day in most aspects of  
 self-care 
 I do not get dressed, I wash with difficulty  








Section 3 – Lifting 
 I can lift heavy weights without extra pain 
 I can lift heavy weights but it gives extra pain 
 Pain prevents me from lifting heavy weights off 
 the floor, but I can manage if they are 
 conveniently placed eg. on a table 
 Pain prevents me from lifting heavy weights, 
 but I can manage light to medium weights if 
 they are conveniently positioned 
 I can lift very light weights 
 I cannot lift or carry anything at all 
 
Section 4 – Walking* 
 Pain does not prevent me walking any distance 
 Pain prevents me from walking more than  
       1 mile 
 Pain prevents me from walking more than  
       1/2 mile 
 Pain prevents me from walking more than  
       100 yards 
 I can only walk using a stick or crutches 
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Oswestry Low Back Disability Questionnaire  
 
Section 5 – Sitting 
 I can sit in any chair as long as I like 
 I can only sit in my favourite chair as long as  
       I like 
 Pain prevents me sitting more than one hour 
 Pain prevents me from sitting more than  
       30 minutes 
 Pain prevents me from sitting more than  
       10 minutes 
 Pain prevents me from sitting at all 
 
Section 6 – Standing 
 I can stand as long as I want without extra pain 
 I can stand as long as I want but it gives me 
 extra pain 
 Pain prevents me from standing for more than  
       1 hour 
 Pain prevents me from standing for more than  
       30 minutes 
 Pain prevents me from standing for more than 
 10 minutes 
 Pain prevents me from standing at all 
 
Section 7 – Sleeping 
 My sleep is never disturbed by pain 
 My sleep is occasionally disturbed by pain 
 Because of pain I have less than 6 hours sleep 
 Because of pain I have less than 4 hours sleep 
 Because of pain I have less than 2 hours sleep 





Section 8 – Sex life (if applicable) 
 My sex life is normal and causes no extra pain 
 My sex life is normal but causes some extra 
 pain 
 My sex life is nearly normal but is very painful 
 My sex life is severely restricted by pain 
 My sex life is nearly absent because of pain 
 Pain prevents any sex life at all 
 
Section 9 – Social life 
 My social life is normal and gives me no extra 
 pain 
 My social life is normal but increases the 
 degree of pain 
 Pain has no significant effect on my social life 
 apart from limiting my more energetic interests 
 eg, sport 
 Pain has restricted my social life and I do not go 
 out as often 
 Pain has restricted my social life to my home 
 I have no social life because of pain 
 
Section 10 – Travelling 
 I can travel anywhere without pain 
 I can travel anywhere but it gives me extra pain 
 Pain is bad but I manage journeys over two 
 hours 
 Pain restricts me to journeys of less than one  
        hour 
 Pain restricts me to short necessary journeys 
 under 30 minutes 
 Pain prevents me from travelling except to  
     receive treatment 
 
. 
 Page 3  
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Appendix	  4:	  Institutional	  Review	  Board	  approved	  consent	  form	  for	  the	  subacute	  low	  
back	  pain	  study.	  
	  
Page 1 of 6
Protocol Title
RESEARCH CONSENT FORM 
Brain Imaging in People with Subacute Low Back Pain
You are being asked to join a research study.  You are being asked to take part in this 
study because you have subacute low back pain.  You do not have to participate in this 
research study.  The main purpose of research is to create new knowledge for the 
benefit of future patients and society in general.  Research studies may or may not 
benefit the people who participate.  
Research is voluntary, and you may change your mind at any time.  There will be no 
penalty to you if you decide not to participate, or if you start the study and decide to 
stop early.  Either way, you can still get medical care and services at the University of 
Kansas Medical Center (KUMC).    
This consent form explains what you have to do if you are in the study.  It also 
describes the possible risks and benefits.  Please read the form carefully and ask as 
many questions as you need to, before deciding about this research.  
You can ask questions now or anytime during the study.  The researchers will tell you if 
they receive any new information that might cause you to change your mind about 
participating.  
This research study will take place at the University of Kansas Medical Center (KUMC) 
with Dr. Neena Sharma as the researcher.  About 20 people will be in the study at 
KUMC.  
BACKGROUND 
Low back pain (LBP) is one of the most common pain conditions worldwide. LBP can 
be in the lower back region and/or the buttocks. LBP can also cause radiating pain 
down in one or both legs. Subacute LBP is defined as continuous or on-and-off pain up 
to 6 months after the first episode of pain. Brain imaging studies help researchers 
understand the pain processing regions within the brain. Previous research has found 
differences in brain volume, function, and chemicals in people with chronic LBP. No 
studies have examined the subacute LBP population. In this study we are interested in 
examining brain volume, brain blood flow, and brain chemicals within the subacute LBP 
population.   
PURPOSE
By doing this study, researchers hope to learn whether individuals with subacute LBP 
have altered brain structure, blood flow, or chemical concentration. Moreover, we hope 
to learn whether any of those brain changes relate to clinical symptoms (such as pain 
intensity, pain duration, and fear of movement).    
PROCEDURES
If you are eligible and decide to participate in this study, your participation will last 
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approximately 2 hours in total. Your participation will involve a clinical testing session 
(physical exam and few standard surveys) and a brain scan (magnetic resonance 
imaging: MRI).
• Clinical testing: Research personnel will do a physical examination on your back. 
Physical exam includes range of motion of your back, sensory and muscle 
testing. Another part of the examination will be the pain pressure threshold 
testing, which includes applying a pressure device to your back while you are 
lying on your stomach and then asking you to click a button once the pressure 
starts becoming uncomfortable (just about to cause pain). You will be asked to fill 
out questionnaires related to pain, physical activity, disability, and depression. 
This may take up to 60 minutes of your time. 
Any medications you are taking will need to be indicated.
• Neuroimaging evaluation: you will have one MRI exam of your brain (a standard 
procedure). The total time for the MRI session will be about 30 minutes. 
Throughout this scan we will be collecting three different types of images. First, 
we will collect structural brain images to look at brain volume. Second, we will 
collect functional brain images to look at the blood flow in the brain. Finally, we 
will collect spectroscopy images to look at the levels of different chemicals in the 
brain. These different types of imaging will be collected during the same session. 
You will lie down on a bed and the researcher will make you as comfortable as 
possible with padding and blankets. Your head and shoulders will be placed in a 
tunnel. As the MRI examination is performed, you will hear loud knocking noises. 
You will be provided ear protection including earplugs or earmuffs or both. You 
might also feel warm during this procedure. This is all normal for an MRI exam. 
You will lie in the tunnel for about one hour. During the functional MRI portion, 
you will be asked to keep your eyes open and look at a “+” sign presented in 
front of you. For the other 2 portions of the scan you can keep your eyes open or 
closed. 
• After 3 and 6 months we will send you an e-mail with an electronic link to a 
webpage that has a survey on it for you to fill up. If you wish we can also send 
you the questionnaires via mail, or we can meet in person and fill up the 
questionnaires. The survey will have the exact same questionnaires you filled up 
on your first visit. 
RISKS
There are potential discomforts and risks to your health and wellbeing if you agree to be 
a subject in this research. Generally, these procedures are considered to be 
noninvasive and safe. However, Dr. Sharma or her associates have discussed this 
research with you and have described them as follows:
Neuroimaging evaluation: MRI studies are among the safest of all non-invasive medical 
procedures, but certain risks and discomforts may be associated with this procedure.
You will complete a MRI Safety Screening Form before your participation in this study.
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You understand that the following risks are most common and should be considered:
• An MRI machine acts like a large magnet. If you have a pacemaker or any metal, 
such as an aneurysm clip, ear implant, or nerve stimulator in your body, you 
cannot have an MRI. If a piece of metal, a device made of metal, or an electronic 
device was on or in your body, especially in your eye, heart, or brain, you could 
be seriously injured by the magnetic field. Precautions have been taken to 
prevent any such event from happening and injuring you. These precautions 
include asking you to identify if you have any of these items in or on your body 
before you participate in the study, and removing all iron-containing objects from 
the room.
• If a piece of metal (such as a tool, keys, or watch) is released into the scanner 
room, you could be injured. This chance is minimized by careful screening and 
by having only trained technicians or assistants in the immediate area, which is 
otherwise restricted.
• If you have a serious medical condition, your heart rate and blood oxygen level 
will be monitored electronically while you are in the magnet. In addition, you will 
have an emergency call button placed in your arm. If you become unconscious 
the study will be stopped immediately and you will be given aid.
• If you do not wear ear protection, the noise could potentially injure your hearing. 
Ear protection will be offered and you should use it to minimize this possibility.
• If you bring credit cards, other magnetic media, or fine electronics or devices 
(such as a watch) into the MRI scanner room, they may be damaged by the 
strong magnetic field; you should remove these objects prior to the procedure.
• Individuals who are claustrophobic may become anxious during the MRI. During 
screening, you will be asked if you have difficulties with enclosed spaces or 
claustrophobia to determine if this is a risk factor for you. Additionally, you 
understand that if you begin to feel anxious during the procedure, you can ask 
the researchers to stop the MRI and discontinue your participation in the study
• Pregnancy Related Risk: It is not known how magnets will affect an unborn child. 
If you are a woman who is pregnant you may not enter this study. 
Clinical evaluation: There are some discomforts that may be associated with clinical 
evaluation. You may become tired or feel pain during physical exam and the pressure 
pain testing. The researcher will stop the testing and will give you rest, as needed. If 
after the rest, you continue to have difficulties completing the testing, the researcher will 
stop the evaluation. In this case, you may withdraw from the study. You might also 
become anxious if you are having difficulty completing these tests. This is normal even 
in people without low back pain. If you wish you could tell the researcher and they will 
let you rest for a while and then restart the evaluation. Some questions may be 
embarrassing or frustrating. You can choose to not answer these questions if they 
make you uncomfortable. 
Possibility of unknown risks: there may be other risks of the study that are not yet 
known.
KUMC IRB # STUDY00002541 | Approval Period 2/17/2016 – 4/22/2016 | FWA# 00003411
	   	   109	  
	  
Page 4 of 6
Protocol Title
NEW FINDINGS STATEMENT
You will be told about anything new that might change your decision to be in this study. 
You may be asked to sign a new consent form if this occurs.  
BENEFITS
You may or may not benefit from this study. Researchers hope that the information 
from this research study may be useful in understanding brain structural, functional, and 
chemical differences in individuals with subacute LBP. Moreover, how do such 
differences relate to clinical presentation of LBP such as pain duration, pain intensity, 
disability, and fear of movement.
 
ALTERNATIVES
Participation in this study is voluntary.  Deciding not to participate will have no effect on 
the care or services you receive at the University of Kansas Medical Center. This study 
does not involve providing you with any medical treatments or medical diagnosis. You 
can get any medical treatments or tests you might need, including MRI testing, without 
having to participate in this study.
COSTS      
There is no cost for being in the study.  
PAYMENT TO SUBJECTS
You will be paid for your participation. You will be offered a stipend of $30 (with a 
check) after the completion of both the clinical examination and the brain scan. If you 
decide to withdraw from the study before the completion of both components (clinical 
examination and brain scan) you will not receive the payment. After the completion of 
both surveys (after 3 and 6 months) you will be compensated with an additional $10.
The KUMC Research Institute will be given your name, address, social security number, 
and the title of this study to allow them to write checks for your study payments. Study 
payments are taxable income. A Form 1099 will be sent to you and to the Internal 
Revenue Service if your payments are $600 or more in a calendar year.  
IN THE EVENT OF INJURY  
If you have a serious side effect or other problem during this study, you should 
immediately contact Dr. Sharma at (913) 588-4566.   If it is after 5:00 p.m., a holiday or 
a weekend, you should call the emergency room.  A member of the research team will 
decide what type of treatment, if any, is best for you at that time. 
If you have a bodily injury as a result of participating in this study, treatment will be 
provided for you at the usual charge.  Treatment may include first aid, emergency care 
and follow-up care, as needed.  Claims will be submitted to your health insurance 
policy, your government program, or other third party, but you will be billed for the costs 
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that are not covered by the insurance. You do not give up any legal rights by signing 
this form.
INSTITUTIONAL DISCLAIMER STATEMENT
If you think you have been harmed as a result of participating in research at the 
University of Kansas Medical Center (KUMC), you should contact the Director, Human 
Research Protection Program, Mail Stop #1032, University of Kansas Medical Center, 
3901 Rainbow Blvd., Kansas City, KS 66160.  Under certain conditions, Kansas state 
law or the Kansas Tort Claims Act may allow for payment to persons who are injured in 
research at KUMC.   
CONFIDENTIALITY AND PRIVACY AUTHORIZATION
The researchers will protect your information, as required by law.  Absolute 
confidentiality cannot be guaranteed because persons outside the study team may 
need to look at your study records.  The researchers may publish the results of the 
study.  If they do, they will only discuss group results.  Your name will not be used in 
any publication or presentation about the study.  
Your health information is protected by a federal privacy law called HIPAA.  By signing 
this consent form, you are giving permission for KUMC to use and share your health 
information.  If you decide not to sign the form, you cannot be in the study.  
The researchers will only use and share information that is needed for the study.  The 
information collected during this research study may also be used for other future 
projects and analyses. To do the study, they will collect health information from the 
study activities. You may be identified by information such as name, address, phone, 
date of birth, social security number, or other identifiers.  Your health information will be 
used at KU Medical Center by Dr. Sharma, members of the research team, the KUMC 
Research Institute, the KUMC Human Subjects Committee and other committees and 
offices that review and monitor research studies. Study records might be reviewed by 
government officials who oversee research, if a regulatory review takes place.  
All study information that is sent outside KU Medical Center will have your name and 
other identifying characteristics removed, so that your identity will not be known. 
Because identifiers will be removed, your health information will not be re-disclosed by 
outside persons or groups and will not lose its federal privacy protection.  
Your permission to use and share your health information will not expire unless you 
cancel it.
QUESTIONS
Before you sign this form, Dr. Sharma or other members of the study team should 
answer all your questions.  You can talk to the researchers if you have any more 
questions, suggestions, concerns or complaints after signing this form.  If you have any 
questions about your rights as a research subject, or if you want to talk with someone 
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who is not involved in the study, you may call the Human Subjects Committee at (913) 
588-1240.  You may also write the Human Subjects Committee at Mail Stop #1032, 
University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160.
SUBJECT RIGHTS AND WITHDRAWAL FROM THE STUDY
You may stop being in the study at any time.  Your decision to stop will not prevent you 
from getting treatment or services at KUMC.  The entire study may be discontinued for 
any reason without your consent by the investigator conducting the study.  
You have the right to cancel your permission for researchers to use your health 
information. If you want to cancel your permission, please write to Dr. Sharma. The 
mailing address is Neena Sharma, PT, PhD, University of Kansas Medical Center, 3901 
Rainbow Boulevard, Kansas City, KS 66160.  If you cancel permission to use your 
health information, you will be withdrawn from the study.  The research team will stop 
collecting any additional information about you.  The research team may use and share 
information that was gathered before they received your cancellation.  
CONSENT
Dr. Neena Sharma or the research team has given you information about this research 
study.  They have explained what will be done and how long it will take.  They explained 
any inconvenience, discomfort or risks that may be experienced during this study.  
By signing this form, you say that you freely and voluntarily consent to participate in this 
research study.  You have read the information and had your questions answered.  




Signature of Participant   Time Date
____________________________________
Print Name of Person Obtaining Consent
____________________________________ __________________
Signature of Person Obtaining Consent Date
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